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ABSTRACT
A total of 402 bovine embryos, non-surgically collected on
day 6.5-7.5 after estrus, were utilized in evaluation of fluorescein
diacetate (FDA) for estimating embryo viability In vitro and to inves
tigate the effect of Bovine Viral Diarrhea (BVD) Virus on embryonic
development during in vitro culture.

Fluorescent assessment, using UV

microscopy (440-480 nm) of embryos after staining in FDA (2.5 pg/ml
phosphate buffered saline: PBS), was found to be a rapid, non-toxic and
accurate method for evaluation of viability.

Embryos with highest

fluorescent scores (Score = 4) prior to culture developed at the
highest rate (95.7%), while embryos with no fluorescence (score = 0)
did not develop.

Significant correlations were found between morpho

logical grading and fluorescent scores (r = .71), although FDA was more
sensitive in estimating positive development.
The investigation of the effect of BVD virus on development
of bovine embryos was divided into three studies:

(1) BVD virus

cultured with live and dead embryos each with and without zona pellu
cida (four treatments),

(2) Micro-injection of BVD virus directly into

the blastocele of blastocysts and (3) transfer of BVD virus-exposed
embryos into recipient cows.

In the first study, live embryos (with

and without a zona pellucida) assessed by FDA, developed at normal
rates when exposed to BVD virus, showing that embryonic development
was independent of the zona pellucida.

xiii

Virus isolation from

sonificated embryos along with attempts to measure the uptake of virus
was unsuccessful.

Transmission electron microscopy (TEM) revealed BVD

virus-like particles beneath the zona pellucida of live embryos
indicating that the virus penetrated the zona pellucida.

TEM

evaluation of live embryos without zona pellucida also revealed BVD
virus-like structures, while no structures resembling the BVD virus
were found in dead embryos with and without zona pellucida.

Micro

injection of BVD virus (Study 2) did not reduce in vitro development
(91.7%) as compared with control medium-injected blastocysts (85.0%)
or non-injected controls (88.3%).

In vitro development was 75 and 71

percent for control and BVD virus-exposed embryos, respectively (Study
3).

BVD serum neutralizing antibodies of recipient females did not

change after transfer of either control and BVD virus-exposed embryos,
indicating that either the virus was not transmitted in the embryos
or medium or that the concentration of virus was not high enough to
stimulate the immunological system of the recipient females.

Preg

nancy rates were 20.0 and 13.3 percent for control and BVD virusexposed embryos at 65 days post-transfer.

Embryonic mortality was

higher in recipients transferred with BVD virus-exposed embryos (5
of 30, 16.7%) compared to controls (3 of 30, 10%); however, this dif
ference was not statistically significant.

xiv

INTRODUCTION
The beef cattle industry is a multi-million dollar business,
and like any other business it must concern itself with making a
profit.

In the economic production of beef cattle, every female

should produce living offspring and raise them to market weight.
Every calf dying before reaching market weight due to abortion or
disease, or every animal retarded due to mismanagement, represents
the loss of a sizeable sum of money to the producer.

Therefore, the

goal of the efficient producer is to reduce the number of losses
from conception to consignment.
Embryo transfer has become a major management practice in
the beef and dairy industry, providing more calves from selected
matings of specific dams and sires.

Improved embryo collecting and

superovulation has enabled more trained technicians to provide embryo
transfer services at a reduced cost to cattlemen.

Skill involved

in predicting fertility of embryos has not developed at a sufficient
rate to compliment other advancements in embryo transfer.

This is

likely due to the inadequacies of grading embryos morphologically.
Therefore, a preliminary study was designed to evaluate the use of
fluorescein diacetate for use in embryo viability scoring.
Bovine virus diarrhea (BVD) is an acute or chronic, con
tagious and infectious disease of cattle.
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It is characterized by

fever, nasal discharge, coughing, profuse watery diarrhea, rapid
dehydration and emaciation.

The disease is considered to be wide

spread, with up to 56 percent of adult cattle having antibodies to
the virus.

The greatest loss to beef cattle producers due to BVD

infection are those dealing with inapparent infection in the herd.
These losses are often related to reproductive failure such as
infertility, fetal absorption, fetal mummification, abortion and
embryonic mortality.
Previous research has demonstrated that the intrauterine
location of the BVD virus could interfere with normal development
of preimplantation bovine embryos.

However, in that study it was

not possible to ascertain whether the effect was due primarily to
the BVD virus, or whether the virus altered the uterine environment
to produce the effects of the BVD virus on preimplantation bovine
embryos using _in vitro techniques.

CHAPTER I

THE USE OF FLUORESCEIN DIACETATE (FDA) TO
ASSESS VIABILITY OF BOVINE EMBRYOS IN VITRO

Introduction
The commercial bovine embryo transfer industry has enjoyed
success in the last few years due largely to technological advances
in embryo collection, transfer techniques and in improved super
ovulation methods (Schneider et al., 1980).

Advances in embryo

culture and grading techniques have also contributed to the overall
growth of the industry.
Embryo grading is an important decision in embryo transfer
because of the need to predict if the embryo is viable and has the
developmental capacity to establish a pregnancy.

Embryo grading is

usually assigned to trained observers who use a simple subjective
system of qualifications.

The embryo grading system is based on

morphological assessments of the cellular mass and to a lesser extent,
of the zona pellucida (Shea, 1981).

In general, bovine embryos are

considered normal when blastomeres are symmetrical and the develop
mental stage of the embryo coincides with the day of estrus on which
the embryo was collected (appendix table 1).

Poor quality embryos

have asymmetrical cell masses, extraneous degenerate cells or, in
the case of blastocysts have a collapsed blastocele (Trounson et al.,
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1976; Shea, 1976; Wishart, 1977; Schneider et al., 1980; Shea, 1981).
Although embryo grading has been described by Church and Shea (1976)
as being a difficult and frustrating process requiring practical
experience, it is a good predictor of pregnancy rates.

Schneider

et al. (1980), citing results of a large commercial bovine embryo
transfer facility, reported a higher pregnancy rate after transfer
of good embryos (70%) than poor embryos (55%).

Shea (1981) also

reported similar results, with Grade 4 embryos (Grade 4 = best)
yielding a 71 percent pregnancy rate while Grade 2 embryos resulted
in a pregnancy rate of 44 percent.

Elsden et al. (1978) found simi

lar results when they classified bovine embryos according to their
morphology as excellent, good, fair and poor; pregnancy rates were
63, 58, 31 and 12 percent, respectively.

In each of these studies,

embryos of poor quality were able to develop after transfer and
establish pregnancies, indicating that some variability existed in
the technique.

Variability in the assessment of viability is open

to misinterpretation by the fact that particular donors yield embryos
of poor quality grade while their pregnancy rate is high when suit
able recipients are used.

On the other hand, some donors produce

high quality embryos but yield a low pregnancy rate.
The lack of precision in the technique of embryo grading
using morphological criteria has prompted researchers to develop
additional tests for evaluating embryo viability.

Assays of via

bility by assessing metabolic activity have been used for rabbit
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embryos (Anderson and Foote, 1974, 1975).

These tests require long

incubation periods and render the embryo nontransferable after the
result of the test.

Renard et al. (1977) worked with an in vitro

test of energy sources and enzyme qualification of the holding medium
of day 10 blastocysts to predict viability.

Another simpler test of

embryo viability is to culture the embryos in question in a medium
of known compatibility.

Bovine embryos often respond favorably to

culture (Wright et al., 1976) and still result in a high pregnancy
rate (Shea, 1981).
Rotman and Papermaster (1966) introduced a test of viability
based upon a fluorochromatic principle.

These authors found that

certain nonfluorescent fatty-acid esters of fluorescein are hydro
lyzed in living cells by esterases yielding free fluorescein.

The

fluorescein accumulates intracellularly and fluoresces upon exci
tation at wave lengths between 440 and 480 nm.

The model described

by Rotman and Papermaster (1966) was that 3'6' diacetyl-fluorescein
(FDA), being non-polar, can readily pass into the cell where it is
hydrolyzed by esterases yielding polar fluorescein.

The polar

fluorescein cannot readily cross the cell membrane and therefore
accumulates intracellularly.

The test is a measure of both esterase

enzyme activity and membrane integrity.

Results utilizing the FDA

test were very encouraging because of its simple, rapid and non-toxic
procedure for embryos.

Leibo and Mazur (1978) utilized the FDA test

to evaluate survival of mouse embryos after freezing and thawing.
Jackowski (1977) showed a high correlation (r = .96) between the
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fluorescence of the embryo and its ability to develop in culture
after freezing.

Evaluation of the viability of bovine embryos

(Schilling and Dopke, 1978; Schilling et al., 1979; Church and Rains,
1980; Looney et al., 1981; Renard et al., 1982), and of mouse embryos
(Mohr and Trouson, 1980) has been demonstrated by fluorescence micro
scopy with FDA.

Observations by these workers were very encouraging,

but more research is needed to be able to establish the embryo's
ability to develop in culture or in vivo.
The specific objectives of this experiment were:
1.

To investigate the relationship between morphological
assessments and fluorometric assessments of stained
embryos at pre-culture and post-culture intervals.

2.

To determine the relationship between fluorometric
assessment of stained embryos and their subsequent
development in vitro.

3.

To determine if the FDA viability test can be utilized
as a practical embryo transfer technique.

4.

To compare the FDA viability test with subjective
grading assessments to determine if one or both can
be used with in vitro embryo culture experiments.

7

Materials and Methods

Experimental Animals
A total of 24 multiparous Gelbvieh crossbred cows served as
donors

for the embryos used in

this study.

The cows ranged in body

weight

from 430 to 560 kg at the time of collection.

The cows were

maintained on common bermudagrass or dallisgrass pasture lots at the
St. Gabriel Experiment Station, St. Gabriel, Louisiana, and were fed
4.5 kg

of a 14 percent protein

high fiber ration per head daily.

study was conducted during the months of May through August.

The

Ample

shade was provided to reduce thermal stress during the period of the
study.

A penile-deflected teaser bull fitted with a chin-ball

marking harness'*' was used to aid in twice daily estrus detection.

Superovulation of Donors
The superovulatory regimen for this experiment consisted of
intramuscular (IM) injections of 5 mg of follicle stimulating hormone

2

(FSH) twice daily at 12 h intervals.

Donors began super

ovulatory treatment on days 9 through 12 (estrus = day 0) but only
after rectal palpation confirmed the presence of a corpus luteum

3
on one or both ovaries.

A 35 mg dose of prostaglandin F 2 a

^Crocket and Kelly, Inc., Broomfield, Colorado.
2

R
FSH-P , Burns-Biotec, Omaha, Nebraska.

3
R
Lutalyse
(dinoprost tromethamine), Upjohn Co., Kalamazoo,
Michigan.
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was administered IM 48 h after the initial FSH injection to induce
luteolysis.

Estrus was expected within 48 h after PGF 2 a injection.

Donors received a total of either 40 or 45 mg of FSH during super
ovulation treatments.

When estrus was detected FSH injections were

discontinued and cows were artifically inseminated (Al) with frozenthawed semen starting 12 hours after the onset of estrus.

Semen used

in this study was from one collection of a single Gelbvieh bull.

Two

units of semen were inseminated at 12 h, 24 h and 36 h after onset
of estrus.

Embryo Collection Technique
Donor cows were returned to separate pasture lots after
superovulation and breeding requirements were fulfilled to avoid
the stress of handling as routine superovulation procedures con
tinued on herd mates.

Non-surgical embryo collection techniques

were employed in this study 7.0 to 7.5 days after estrus

day 0).

(estrus =

Donors were initially prepared for collection by admin4

istration of 10 or 15 mg Acepromazine

IM.

Cows were also given an

epidural injection of 3 to 5 ml of Carbocaine^ to reduce rectal
contractions during the collection process.

The donors were then
6

placed in lateral recumbency on a tilting stock table
mately 38-40° angle.

at approxi

After cleansing the external genitalia with

^Acepromozine, Fort Dodge Laboratories, Fort Dodge, Iowa.
^Carbocaine, Winthrop Laboratories, New York, New York.
^Tilting Stock Table, Powder River Co., Provo, Utah.

fresh water, a Foley

R

catheter
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was passed through the cervical canal,

the inflatable cuff was seated at the internal os of the cervix, and
the cuff filled with 5 to 7 ml of physiological saline.

Approximately

Q

420 ml of sterile Dulbecco's phosphate buffered saline

(PBS) con-

q
taining 2 percent fetal calf serum

(FCS) and 1 percent antibiotic-

antimycotic solution consisting of 100 IU Penicillin, 100 yg Streptomycin and .25 yg Fungizone

10

(appendix table 2) were infused in

60 to 120 ml increments utilizing a sterile tubing with luer-lock
and sterile 60 ml syringes.

PBS was infused while rectal manipula

tion of the uterus was performed to insure that the medium flowed
throughout each uterine horn simultaneously.

Medium was recovered

from the uterus into the empty 60 ml syringe and a replacement
syringe filled with fresh medium was inserted to keep a closed
system.

The flushing procedure continued until all of the medium

was infused and recovered from the uterus.

In cases of poor recovery

of the medium from the uterus, 80 IU oxytocin"^ was administered
intravenously (IV) into the coccygeal vein to induce uterine con
tractions and evacuation of any unrecovered medium from the uterus.
7

Foley

R

catheter,

C. R. Bard, Inc., Murry Hill, New Jersey.

g

Dulbecco's Phosphate Buffered Saline, Grand Island Biologi
cal Co., Grand Island, New York.
9
Fetal Calf Serum, Grand Island Biological C o . , Grand Island,

New York.
■^Antibiotic-Antimycotic Solution, Grand Island Biological Co.,
Grand Island, New York.
"^Oxytocin, The Butler Company, Columbus, Ohio.
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induce uterine contractions and evacuation of any unrecovered medium
from the uterus.

Embryo Handling
Immediately after collection procedures the recovered media
was placed in sterile containers (100 x 15 mm graded petri-dish
and examined by two observers using a stereomicroscope.

12

)

When an

embryo was located, it was aspirated by a sterile handling pipette
and transferred to a holding dish
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(35 x 10 mm) containing holding

medium (PBS with 20 percent FCS and the standard concentration of
antibiotics and antimycotic).

After each petri-dish was examined

by both observers, the embryos were evaluated and their number
recorded.

Embryos remained in the holding medium at room temperature

(24-28°C).

FDA Viability Test
A stock solution of 5 mg of fluorescein diacetate^ (3'6T
diacetyl fluorescein; 5 mg/ml in acetone) was prepared and stored
in an aluminum covered glass vial in a dessicator at -20°C.

Imme

diately prior to use, the staining solution (2.5 pg/ml) was prepared
by adding 0.5 pi stock solution per ml PBS.

Embryos were incubated

12

Quebec Grid Petri-Dish 100 x 15 mm, Lab Tek, Products,
Division of Miles Laboratory, Naperville, Illinois.
13

Falcon Petri-Dish 35 x 10 mm, Falcon Division of BectonDickinson, Oxnard, California.
14
Missouri.

Fluorescein Diacetate, Sigma Chemical Co., St. Louis,
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in this staining solution for 60 seconds at room temperature
(24-28°C).

Embryos were then transferred to a microconcavity slide

containing holding medium for microscopic evaluation.

The embryos

were examined at 100 X with an Olympus BH photomicroscope with phasecontrast optics.

All observations under ultraviolet (UV) light were

carried out using the Olympus combination of filters (Olympus RFL)
which contained an excitor filter BG-12, chromatic beam splitter
DM-500 + 0-515 and a barrier filter 0515.

Fluorescence was evaluated

by subjective measurements at 10 to 20 seconds of UV observation of
each embryo.

Fluorescence was scored in the following manner:

Score

4, very bright and uniform fluorescence; Score 3, bright and uniform
fluorescence; Score 2, pale and uniform or patchy fluorescence within
cells; Score 1, pale, often patchy fluorescence within cells just
detectable visually and Score 0, no fluorescence visible.

Morphological Classification Assessments of Embryos
Embryos were classified morphologically as follows.

Unfer

tilized ova were characterized by a thick zona pellucida and the
appearance of a smooth edge surrounding the cellular mass.

Two-cell

through the 32-cell stage embryos were classified by actually coun
ting the number of distinct blastomeres within the zona pellucida.
Morulae

are embryos containing more than 32 blastomeres and had not

yet coalesced to form a compact mass.

Advanced morulae were dis

tinguished from a morula primarily on the basis that the cellular
mass had coalesced but not developed a blastocoele.

Early

12

blastocysts were embryos exhibiting a small blastocoele with the
appearance of a 'signet ring.'

Blastocysts were identified by the

blastocoele which had expanded to fill at least one-half of the entire
cell mass within the zona pellucida.

Expanded blastocysts were char

acterized by a fully expanded blastoceolic cavity which filled the
entire zona pellucida.

Hatched or Hatching blastocysts were iden

tified as those which had shed the zona pellucida completely or were
undergoing this process.

Morphological Grading
Morphological assessments were graded in the following manner.
Grade 1, cellular masses symmetrical, developmental stage correct for
day post-estrus on which collection occurred, blastomeres non-pyknotic;
if blastocysts are encountered the blastocelic cavity must not be
collasped; Grade 2, extruded blastomeres present, cellular mass par
tially asymmetrical and partially pyknotic; Grade 3, cell mass irreg
ular, asymmetrical and partially pyknotic, extruded blastomeres not
attached to functional cell mass, cytoplasm appeared to be granular
and freely movable when embryo was moved; extruded cells were pyknotic
giving the cellular mass a dark appearance; Grade 4, embryos entire
cellular mass pyknotic, cytoplasm was loosened and had no integrity
within the blastomeres, zona pellucida might appear flat indicating
advanced degeneration.
a Grade of 0.

Unfertilized ova (UFO) were routinely given
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Embryo Culture
Embryos and ova were cultured individually in 24-well
covered disposo-trays^ for twelve hours.

Each embryo or ova was

held in 2 ml of holding medium (appendix table 3).

The culture

media was filtered through a 0.22 pm millipore f i l t e r ^ immediately
before use in the culture system.

The dispo-tray was maintained in

a humidified air atmosphere at 37°C during the culture period.
Upon the conclusion of the 12 h culture period the embryos were
transferred to sterile microconcave slides containing holding
medium for post-culture evaluation.

Post-culture evaluation was

performed using criteria previously described for pre-culture embryos.

Statistical Analysis
Each embryo and ova was treated with the FDA staining solu
tion and observed by one observer using a double-blind approach.
Embryos and ova were individually evaluated and cultured throughout
the experiment.

The percentages of embryos and ova developing in

culture as assessed by pre-culture and post-culture morphological
grade and fluorescence were not subjected to statistical analysis,
but were utilized to portray trends in discussing the data.

Simple

correlations (Sail, 1979, Statistical Analysis Systems) were obtained
on data from pre-culture and post-culture morphological grade and

^ L i n b r o Multi-dish Disposo-Trays, Linbro Scientific Co.,
Inc., New Haven, Connecticut.
^Acrodisc^, Gelman Sciences, Inc., Ann Arbor, Michigan.
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fluorescence and resulting development in vitro.

Least squares

analysis of variance was performed using the general linear model
procedure of the Statistical Analysis System (Goodnight, 1979).
The dependent variables utilized in the analysis were the embryo
viability indicators, morphological grade, and fluorescence.

The

independent variables were culture time and result of development
of the embryos in culture, as well as the interaction of culture
time by result of development.
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Results and Discussion
A total of 162 embryos and ova were non-surgically collected
from 24 superovulated Gelbvieh crossbred cows.
embryos and ova were collected per donor.

A mean of 6.75

The mean recovery rate

in this experiment was lower than that collected from 519 super
ovulated donors (9.95 ova/donor) as reported by Schneider et al.
(1980), but is higher than the 4.1 ova/donor previously reported by
Looney et al. (1981).
In table 1, the 162 embryos and ova are classified by pre
culture morphological classification.

A total of 38 unfertilized

ova (UFO) were present, which accounted for 23.5 percent of the
total embryos and ova collected.

The number of unfertilized ova

collected from superovulated donor cattle is variable and can be
attributed to semen quality, insemination interval and individuality
of donors (Moore, 1975; Nelson et al., 1976; Shea et al., 1976).
Schneider et al. (1980) reported 18.0 percent unfertilized ova from
a total of 5169 embryos and ova collected and Looney et al. (1981)
found similar results with 21.5 percent unfertilized ova from a
total of 489 embryos and ova collected.

A relatively small number

of embryos of the two-cell (2 Cell), four-cell (4 Cell), sixteen-cell
(16 Cell) and thirty-two cell (32 Cell);

(n = 2, 2, 1 and 4, respec

tively) stages were collected from the 24 donors.

Embryos in these

morphological stages are considered abnormal when they were found in
flushings from donors on day 7 of diestrus (Seidel et al., 1980).
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TABLE 1.

FREQUENCIES OF MORPHOLOGICAL CLASSIFICATIONS
OF EMBRYOS BEFORE CULTURE

Morphological classification

Unfertilized Ova
Two Cell
Four Cell
Sixteen Cell
Thirty-two Cell
Morula
Advanced Morula
Early Blastocyst
Blastocyst
Expanded Blastocyst
Total

No.

38
2
2
1
4
63
9
21
1
21
162

Percent of total

23.5
1.2
1.2
0.6
2.5
38.9
5.6
12.9
0.6
12.9
100.0%
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The combination of all of these abnormal embryos accounted for only
5.5 percent of the total embryos and ova collected.

The morula (MOR)

morphological classification was the embryo stage represented most
frequently (n = 63).

This observation is in agreement with Seidel

et al. (1980) who reported that the morula or tight (advanced) morula
were normally found on 5-7 days of the donor's estrous cycle.

MOR

and advanced morula (AMOR) classifications combined accounted for
44.5 percent of the total embryos and ova collected.

The combined

morphological classification of all blastocysts accounted for 26.4
percent of the total embryos and ova collected.

This morphological

classification was sub-divided into early blastocyst (ERB; n = 21),
blastocyst (BLA; n = 1) and expanded blastocyst (EXB; n = 21) and
were found at frequencies of 12.9,

.6 and 12.9 percent, respectively.

Pre-culture morphological classifications and subsequent
development of embryos in vitro is shown in table 2.

None of the

UFO, or the 2 Cell through 32 Cell embryos developed in culture.
While only 20.6 percent of the MOR classification developed in vitro,
the combined blastocyst morphological classification had a greater
percentage of embryos developing (76.7%) than any other morphological
classification.

Pregnancy rates of embryo transfers from morula

(44%) have been shown to be significantly lower than that of blasto
cysts (66%) (Wright, 1981).

Table 3 presents the post-culture morpho

logical classification of embryos and ova with their result in
development.

Higher percentages of the later morphological

classifications of embryos resulted in development in vitro.

A
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TABLE 2.

PRE-CULTURE MORPHOLOGICAL CLASSIFICATION
OF EMBRYOS AND OVA AND DEVELOPMENT AFTER
CULTURE

No. of embryos
developing in vitro

% Developing

38

0

0

Two-Cell

2

0

0

Four-Cell

2

0

0

Sixteen-Cell

1

0

0

Thirty-two-Cell

4

0

0

63

13

20.6

9

8

88.9

21

15

71.4

1

0

0

21

18

85.7

162

54

33.3

Pre-culture morphological
classification

Unfertilized ova

Morula
Advanced morulae
Early blastocysts
Blastocysts
Expanded blastocysts
Total

(n)
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TABLE 3.

POST-CULTURE MORPHOLOGICAL CLASSIFICATION
OF EMBRYOS AND OVA AND DEVELOPMENT AFTER
CULTURE

Pre-culture morphological
classification

No. of embryos
developing in vitro

7o Developing

38

0

0

Two-Cell

2

0

0

Four-Cell

2

0

0

Sixteen-Cell

4

0

0

Thirty-two-Cell

4

0

0

55

4

7.3

2

0

0

10

4

40.0

3

2

66.7

Expanded blastocysts

32

28

87.5

Hatching blastocysts

13

12

100.0

162

54

33.3

Unfertilized ova

Morula
Advanced morulae
Early blastocysts
Blastocysts

Total

(n)
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total of thirteen hatched blastocysts (HTB) were formed from
developing blastocysts and resulted in a 100% in vitro development.
Morphological grading of embryos is considered to be one of
the most important decisions made in the embryo transfer procedure.
The ability to successfully predict embryo development by morpho
logical grading only is acquired by diligent practice and profes
sional training.

Pre-culture morphological grading assessments of

embryos and their subsequent development in culture is depicted in
table 4.

Embryos receiving pre-culture Grades of 1 had the greatest

probability of developing (82.5%).

Pre-culture Grade of 2 was

almost as good with 61.3 percent developing; of Grade 3 embryos,
only 6.9 percent resulted in positive in vitro development.

None

of the 24 Grade 4 embryos resulted in positive development.

Although

great subjectivity is known to exist in grading embryos morpholog
ically, and large variability exists between embryo transplant
laboratories, similar results have been reported by Wright (1981)
and Shea (1981).

Similar trends in post-culture grading assessments

of embryos (table 5) were found as were discussed in pre-culture
morphological grade assessments.

Generally, the lower morphological

grade the higher the percentage of embryos that result in positive
in vitro development.

Unlike the pre-culture assessments, there were

three of 52 embryos (5.8%) that developed in vitro to a post-culture
morphological grade of 4.

A total of 54 embryos resulted in positive

in vitro development for an overall culture development rate of 43.5
percent.
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TABLE 4.

PRE-CULTURE MORPHOLOGICAL GRADING ASSESSMENTS OF
EMBRYOS AND THEIR SUBSEQUENT DEVELOPMENT
IN CULTURE3

Pre-culture grades

No. of embryos
developing
in culture
(n)

% embryos developing

1

40

33

82.5

2

31

19

61.3

3

29

2

6.9

4

24

0

0

124

54

Total

aOnly fertilized ova included.

43.6
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TABLE 5.

POST-CULTURE MORPHOLOGICAL GRADING ASSESSMENTS OF
EMBRYOS AND DEVELOPMENT IN VITRO3

Post-culture grades

(n)

No. of embryos
developing in culture

% developing

1

31

30

96.8

2

21

14

66.7

3

13

7

35.0

4

52

_3

5.8

Total

124

54

43.5

Only fertilized ova included.
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Table 6 demonstrates the use of pre-culture fluorometric
assessments with FDA viability stain as first described by Rotman
and Papermaster (1966).

Only one UFO fluoresced at pre-culture

evaluation out of a total of 38 (2.6%).
score of this UFO was 2.5.

The individual fluorometric

FDA has been utilized to indicate via

bility of unfertilized mouse ova (Jackowski, 1977) when collected
near the time of ovulation, but considerable degeneration of bovine
UFO was apparent when collected on day 7 of the estrous cycle.

Since

fluorometric scores of UFO were predominately 0, UFO were deleted
from these tabular data.

No development was observed of embryos given

fluorometric scores of 0 or .5, while embryos with increasing fluoro
metric scores of 1 through 4, showed correspondingly improved per
centages of positive development in vitro.
fluorescent

Embryos with the highest

score of 4 (n = 23) proved to have the highest percen

tage of positive development in vitro (95.7%).

Post-culture fluoro

metric scores of embryos (table 7) gave a better indication of
positive development in vitro.

Only 9.3 percent of all embryos

showing any fluorescence after 12 h of culture did not result in
positive development (5/54).

These results are in general agree

ment with those of Nieman et al.

(1981) who reported that only 16.3

percent of embryos which showed positive fluorescence did not develop
in vitro.

Nieman et al.

(1981) also reported that the use of FDA

increased the accuracy of embryo evaluation in their laboratory by
8 to 10 percent.
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TABLE 6.

PRE-CULTURE FLUOROMETRIC ASSESSMENTS OF EMBRYOS
AND THEIR DEVELOPMENT AFTER CULTURE3

Pre-culture fluorometric
scores

(n)

No. of embryos
developing in culture

% developing

0.0

14

0

0

1.5

6

0

0

1.0

15

1

6.7

1.5

6

1

16.7

2.0

18

7

38.9

2.5

18

9

50.0

3.0

21

12

57.1

3.5

3

2

66.7

4.0

23

22

95.7

Total

124

54

43.5

£

Only fertilized ova included.

25

TABLE 7.

POST-CULTURE FLUOROMETRIC ASSESSMENTS OF
EMBRYOS AND DEVELOPMENT AFTER CULTURE3

Post-culture fluorometric
grades
(n)

No. of embryos
developing Iji vitro

% developing

0.0

70

6

8.6

0.5

18

14

77.8

1.0

11

10

90.9

1.5

—

—

—

2.0

2

1

50.0

2.5

3

3

100.0

3.0

6

6

100.0

3.5

10

10

100.0

4.0

4

4

100.0

Total

124

54

43.5

Only fertilized ova included.
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Simple correlations between viability indicators of embryos
that resulted in positive development (table 8) indicated that a
strong negative relationship existed between morphological grading
assessments and fluorometric scores of pre-culture and post-culture
evaluations.

Strong positive relationships exist between pre-culture

morphological grading assessments and post-cultural grading assess
ments, as well as between pre-culture fluorometric scores and post
culture scores.

Although all possible relationships are statistically

significant, the strongest relationship is found between pre-culture
morphological grade and pre-culture fluorescence (r = -.71; P < .0001).
Simple correlations between viability indicators of embryos and ova
that resulted in negative development (table 9) support a somewhat
lesser degree of relationship as compared with simple correlations
of viability indicators of embryos that resulted in positive develop
ment in vitro.

A significant positive relationship was found between

pre-culture morphologicasl grade and pre-culture fluorescence scores.
This relationship was realized probably by assessments of morpho
logical grade indicating high quality embryos but with poor fluo
rescence scores.

Therefore, this phenomenon probably accounted for an

undetermined number of embryos that resulted in negative development
which were either dead or dying at the time of pre-culture evaluation
as assessed by the more biologically sensitive FDA test.

These same

embryos were previously assessed morphologically as being of a high
quality.
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TABLE 8.

SIMPLE CORRELATION COEFFICIENTS OF VIABILITY
INDICATORS OF EMBRYOS THAT DEVELOPED
IN VITRO3

PRE-GRADE1

PRE-GRADE

PRE-FLUOR2

—

.60***
—

PRE-FLUOR

POST-GRADE3

-.43**
—

POST-GRADE

POST-FLUOR4

-.62***
.66***
-.60***

an = 54
"^PRE-GRADE = pre-culture morphological grade assessment.
2

PRE-FLUOR = pre-culture fluorometric score.

3
POST-GRADE = post-culture morphological grade assessment.
^POST-FLUOR = post-culture fluorometric score.
**P < .01.
***P <

.001.
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TABLE 9.

SIMPLE CORRELATION COEFFICIENTS OF VIABILITY
INDICATORS OF EMBRYOS AND OVA THAT DID NOT
DEVELOP IN V ITRO 3

PRE-GRADE 1

PRE-GRADE
PRE-FLUOR
POST-GRADE

—

PRE-FLUOR 2

. 29 **
—

POST-GRADE 3

.93***
-. 49 ***
—

POST-FLUOR 4

-.003
.32**

.02

an = 108
"^PRE-GRADE = pre-culture morphological grade assessment.

2

PRE-FLUOR = pre-culture fluorometric score.

3
POST-GRADE = post-culture morphological grade assessment.

4 POST-FLUOR = post-culture fluorometric score.
**P < .01
***P < .001
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Mean values for pre-culture and post-culture viability
indicators of grade and fluorescence of all morphological classi
fications of embryos and ova are shown in table 10.

Mean pre- and

post-culture grading assessment scores decreased, indicating
increasing viability, as the morphological classification of embryos
and ova developed into stages that are usually considered normal
for non-surgical collection at day 7.0 post-estrus.

Correspondingly,

increasing fluorescence at both pre- and post-culture assessments
indicated greater viability of embryos that are further developed
and were characteristic of morphological classification from donors
non-surgically collected at day 7.0-7.5 after estrus.

The morpho

logical classification of hatched blastocysts (HTB) was not repre
sented in pre-culture assessments, since they developed from expanded
blastocysts during in vitro culture.

These HTB (n = 13) had the

lowest overall mean grading assessment score (1.23) and the highest
mean fluorescence score (2.88) of all embryos evaluated at the post
culture evaluation.
In table 11 are the mean values for grade and fluorescence
scores for embryos and ova by positive or negative in vitro develop
ment during culture.

Embryos of the thirty-two cell, sixteen-cell,

four-cell and two-cell stages and unfertilized ova did not result in
positive in vitro development.

Morphological grade and fluorescence

scores of these negative developing embryos were a constant indication
of cellular degeneration and decreased viability.

Morphological

grades and fluorescence scores of MOR through HTB were lower and

TABLE 10.

Morphological
classification
UFO

MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS OF
MORPHOLOGICAL CLASSIFICATIONS OF EMBRYOS AND OVA

Pre-■culture assessments
Fluorescence
Grade

(n )

Post--culture assessments
Grade
Fluorescence

38

.0

.0

.5

2

4.0

.0

4.0

.5

2

4.0

.0

1

4.0

.5

1

4.0

.0

4

3.75

1.25

3

4.0

.0

63

2.84

1.69

55

3.67

.09

9

1.33

2.55

2

2.00

1.00

ERB

21

1.69

2.52

10

2.45

.75

BLA

1

1.00

3.00

3

2.67

.16

EXB

21

1.69

2.52

33

1.63

1.45

HTB

—

13

1.23

2.88

38

.0

2 Cell

2

4.0

4 Cell

2

16 Cell
32 Cell
MOR
AMOR

—

.06

(n)

—

Morphological classification: UFO = unfertilized, 2 Cell = two cell, 4 Cell = four cell,
16 Cell = sixteen cell, 32 Cell = thirty-two cell, MOR = morula, AMOR = advanced morula, ERB =
early blastocyst, BLA = blastocyst, EXB = expanded blastocyst and HTB = hatched blastocyst.

TABLE 11.

Morphological
classification

MEAN VALUES FOR VIABILITY. INDICATORS FOR EMBRYOS AND OVA THAT RESULTED
IN POSITIVE AND NEGATIVE IN VITRO DEVELOPMENT BY ALL MORPHOLOGICAL
CLASSIFICATIONS

Positive i n - y i t m development
Grade
Fluorescence
(n )

Negative in.-vitro development
Fluorescence
Grade
(n )

UFO

0

—

—

76

.00

.03

2 Cell

0

—

—

4

4.00

.25

4 Cell

0

—

—

4

4.00

.25

16 Cell

0

—

—

2

4.00

.25

32 Cell

0

—

—

7

3.86

.71

MOR

17

2.29

2.18

101

3.86

.74

AMOR

10

1.40

2.40

1

2.00

1.00

ERB

19

1.70

2.55

12

2.29

1.00

BLA

2

2.00

.25

2

2.50

1.50

EXB

47

1.33

2.54

7

2.00

1.42

HTB

13

1.23

2.88

0

—

—

Morphological classification: UFO = unfertilized, 2 Cell = two-cell, 4 Cell = four-cell,
16 Cell = sixteen-cell, 32 Cell = thirty-two-cell, MOR = morula, AMOR = advanced morula, ERB =
early blastocyst, BLA = blastocyst, EXB = expanded blastocyst and HTB = hatched blastocyst.

32

higher, respectively, for embryos showing positive development as
compared with embryos showing negative development in culture.

Since

matched blastocysts resulted in 100 percent positive development in
vitro no values appear in the negative in-vitro development segment
of table 11.
Analysis of variance (table 12) indicated significant dif
ferences occurred for morphological grade assessments between
positive and negative developing MOR and EXB.

There was also sig

nificant variation of morphological grade assessments between preand post-culture evaluation times of MOR and EXB, while the AMOR
classification approached significance (P

< .10).

A significant interaction between result and culture time
(P < .05) for morula morphologically classified embryos indicated
that MOR resulted in positive or negative in vitro development dif
ferently due to culture time.

This interaction can be explained

by the fact that some embryos responded readily to in vitro culture
and exhibited post-culture morphological grading assessments to
indicate high quality (low grading scores)

whereas their pre-culture

grading scores indicated low quality (high grading scores).

Morulae

also had the widest ranges of morphological grading assessments of
all the different embryo classifications.

Wright (unpublished data)

has suggested that the uterine environment of superovulated donors
becomes hostile due to a distinct imbalance in the hormonal patterns.
This hostile environment may retard the embryo for a short time
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TABLE 12.

ANALYSIS OF VARIANCE OF FDA-TREATED EMBRYOS BY
MORPHOLOGICAL CLASSIFICATION OF GRADE
ASSESSMENTS

Mean squares for morphological grade
Morphology classification3
Source

Result (R)
Culture Time (C)

ERB

BLA

.50

1.13

2.67

2.49*

.90 +

2.50

4.50

4.29**

MOR

AMOR

4.92**
13.00**

EXB

R x C

2.57*

—

.08

Error

.44

.19

.57

2.00

.462

(8)

(27)

(1)

(49)

(114)c

—

.59

aMorphology classification : MOR = morula, AMOR = advanced
morula, ERB = early blastocyst, BLA = blastocyst and EXB =
expanded blastocyst.
^Morphology classification of thirty-two cell or less and
hatched blastocyst were not represented in either result and/or
culture time.
cError (df)
+P <

.10

*P <

.05

**P < .01
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without causing death and may account for its subsequent favorable
response in culture.
Analysis of variance (table 13) indicated significant vari
ation of fluorescent

assessments between positive and negative

developing morula, early blastocysts and expanded blastocysts, while
the advance morula morphological classification approached signifi
cance (P < .10).

A significant variation of fluorescent

assessments

was also found between pre-culture and post-culture evaluations for
thirty-two cell, morula and expanded blastocysts, while advanced
morula and blastocysts approached significance (P <

.10).

Least squares means are shown in tabular form (table 14) for
morphological grade assessments of embryos and ova by culture time.
A significant increase in morphological grading scores indicated
poorer embryo viability of post-culture assessments of both MOR
and EXB classifications.

Post-culture morphological grades tended

to be lower in embryos of normal developmental classifications than
pre-culture grades, but these differences were not significant.
Least squares means of morphological grade assessments for the
small number of embryos, representing abnormal morphological clas
sifications (thirty-two cell, sixteen cell, four cell, two cell)
were essentially the same for both the pre-culture or post-culture
evaluation times.
Fluorescent

scores represented by least squares means are

shown in table 15 for all morphological classifications of embryos
and ova by pre- and post-culture evaluation time.

A significantly

TABLE 13.

ANALYSIS OF VARIANCE OF FDA TREATED EMBRYOS BY
MORPHOLOGICAL CLASSIFICATION OF FLUORESCENT
ASSESSMENTS

Mean squares for fluorescence
Morphology classification
Source

UFO

2 Cell

4 Cell

32 Cell

Result (R)

—

—

—

—

Culture Time (C)

00
o

.25

.25

2.68**

R X C

—

—

—

.25
(2)

.25
(2)

Error

.08
(74) c

—

.05
(5)

MOR

AMOR

ERB

8.64**

2.72t

7.73**

32.09**

4.90

1.07

—

.53
(114)

.68
(8)

12.28
.04
1.0
(27)

BLA

EXB

.04

7.75*

4.50t

41.60**

—
.125
(1)

.915
1.153
(49)

Morphology classification: UFO = unfertilized, 2 Cell = two-cell, 4 Cell = four-cell, 32 Cell =
thirty-two cell, MOR = morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded blastocyst.
Sixteen cell and hatched blastocyst morphology not represented in result or culture time.
cError (df)
tP < .10

*P < .05
**P < .01

LO
Ui
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TABLE 14.

Morphological a ^
classification ’

LEAST SQUARES MEANS AND STANDARD ERRORS OF
MORPHOLOGICAL GRADE ASSESSMENTS AT
PRE-CULTURE AND POST-CULTURE TIMES

Culture time
Pre-culture

Post-culture

.00 + .000

2 Cell

4.00 + .000

4.00 + .000

4 Cell

4.00 + .000

4.00 + .000

16 Cell

4.00 + .000

4.00 + .000

32 Cell

3.75 + .194

4.00 + .224

MOR

2.50 +

AMOR

1.63 + .229

2.38 + .383

ERB

1.78 + .182

2.39 + .243

BLA

1.00 + 1.53

2.67 + .882

EXB

1.17 + .211°

2.01 + .182'

a
o
o

.00 + .000

UFO

3.59 + .173'

Morphological classification:
UFO = unfertilized, 2 cell =
two cell, 4 cell = four cell, 16 cell = sixteen cell, 32 cell = thirtytwo cell, MOR = morula, AMOR = advanced morula, BLA = blastocyst and
EXB = expanded blastocyst.
^Hatched blastocyst was not represented in pre-culture assess
ment and was not included in these data.
c d
’ Values in the same row with different superscripts differ
(P < .01).
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TABLE 15.

Morphological
classification3 ’^

LEAST SQUARES MEANS AND STANDARD ERRORS OF
FLUORESCENT ASSESSMENTS AT PRE-CULTURE
AND POST-CULTURE TIMES

Culture time
Pre-culture

Post-culture

UFO

.06 + .047

.00 + .047

2 Cell

.50 + .350

.00 + .350

4 Cell

.50 + .350

.00 + .350

16 Cell

.50 + .350

.00 + .350

32 Cell

1.25 + .110c

.00 + .130'

MOR

2.05 + .113°

.34 + .188'

AMOR

1.88 + .439

.13 + .732

BLA

3.00 + .288c

.16 + .167'

EXB

3.38 + .280°

1.02 + .250'

Morphological classification: UFO = unfertilized, 2 Cell =
two cell, 4 Cell = four cell, 16 Cell = sixteen cell, 32 Cell = thirtytwo cell, MOR = morula, AMOR = advanced morula, BLA = blastocyst and
EXB = expanded blastocyst.
^Hatched blastocyst was not represented in pre-culture assessment
and was not included in these data.
c ’M a l u e s in the same row with different superscripts differ
(P < .01).
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higher fluorescence score was found at pre-culture evaluations as
compared to post-culture evaluations of thirty-two cell, morula,
blastocyst and expanded blastocyst embryos.
(1980)

Mohr and Trounson

indicated that loss of intracellular fluorescein was affected

by culture time of the stained embryos and the temperature at which
the embryos were stored.
Table 16 contains the least square means of morphological
grade assessments of embryos that resulted in positive or negative
development during in vitro culture.

Morphological classifications

of morula and expanded blastocysts that resulted in positive in vitro
development had significantly lower morphological grading scores,
indicating greater embryo viability, than did embryos that resulted
in negative in vitro development.

In general, morphological grading

scores were lower for embryos that resulted in positive in vitro
development compared to embryos that did not show any positive
development.

These observations are in general agreement with data

from Schneider (1980) where embryos of morphological grades indi
cating good viability resulted in higher pregnancy rates compared with
embryos given morphological grades indicative of poorer quality.
Fluorescent

assessments of embryos that resulted in posi

tive in vitro development were higher than for embryos that resulted
in negative development (table 17).

Significantly increased fluo

rescence scores were found in positive developing embryos of the
morphological classifications of morula, advanced morula, early
blastocyst and expanded blastocyst.

Schilling et al. (1979) reported
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TABLE 16.

LEAST SQUARES MEANS AND STANDARD ERRORS OF MORPHOLOGICAL
GRADE ASSESSMENTS OF EMBRYOS THAT RESULTED IN POSITIVE
OR NEGATIVE DEVELOPMENT IN CULTURE

Morphological
classification3 ’^

Positive

Result in culture________
Negative

MOR

2.71 + .190c

3.38 + .066d

AMOR

1.63 + .171

2.38 + .466

ERB

1.89 + .190

2.29 + .214

BLA

2.00 + 1.275

2.50 + 1.275

EXB

1.26 + .103c

1.96 + .258d

aMorphological classification: MOR = morula, AMOR = advanced
morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded
blastocyst.
Morphological classifications of thirty-two cell embryos or
less and unfertilized ova did not result in development and are not
represented in these data.
c d
’ Values in the same row with different superscripts differ
(P < .01).

40

TABLE 17.

Morphological
classificationa,k

LEAST SQUARES MEANS AND STANDARD ERRORS
OF FLUORESCENT ASSESSMENTS OF EMBRYOS
THAT RESULTED IN POSITIVE OR NEGATIVE
DEVELOPMENT IN CULTURE

Result in culture
Positive

Negative

MOR

1.64 + .208c

.750 + .072d

AMOR

1.88 + .330c

.125 + .892d

ERB

2.12 + .282°

1.00 + .290d

BLA

1.75 + .354

1.50 + .250

EXB

2.79 + .162°

1.65 + .410d

aMorphological classification: MOR = morula, AMOR = advanced
morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded
blastocyst.
^Morphological classifications of thirty-two cell embryos or
less and unfertilized ova did not result in development and are not
represented in these data.
c d
’ Values in the same row with different superscripts differ

(P < .01).
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similar observations when utilizing the FDA viability test on early
bovine embryos.

In this latter study a 24 h incubation period was

utilized to evaluate embryo mitotic activity and results indicated
a higher percentage of mitotic activity was associated with the
greatest amount of fluorescence at the preculture evaluation time.
Several reports also reflect this general agreement associated with
higher fluorescent scores and positive development in culture (Renard
et al., 1982; Jackowaski, 1977; Nieman et al., 1981).

REVIEW OF LITERATURE
Olafson et al. (1946) described an apparently new disease of
dairy cattle in the state of New York.

The disease was found to be

contagious, and could be transmitted to non-affected cattle by
parenteral injection of defibrinated blood, splenic tissue and other
organs.

Pritchard et al. (1954) later described a similar disease

in dairy and beef cattle in Indiana.

For a short time the researchers

thought the two diseases were entirely different and were described
as virus diarrhea in the state of New York and virus diarrhea in the
state of Indiana.

Gillespie and Baker (1959) compared the Indiana

and New York strains of the virus and found no immunological or
clinical differences between them.

At this time it was proposed

that only one strain of virus diarrhea existed in the United States.
Ramsey and Chivers (1953), while working with cytopathogenic
strains of the virus known to cause mucosal disease,found similar
ities to the cytopathogenic strains of virus diarrhea.

In 1971,

the American Veterinary Medical Association termed the disease
collectively as bovine virus diarrhea-mucosal disease.

Disease Prevalance
Bovine virus diarrhea (BVD) has been diagnosed in many
countries of the world including the United States, Australia,
Canada, Germany, England, Scotland, Sweden, Japan, and Argentina.
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The only reported clinical cases of this worldwide disease involve
cattle of all ages and is most frequently found during the late winter
and spring (Gillespie and Timoney, 1981).
Kahrs et al. (1964) found that 53 percent of all cows in a
New York state study had antibodies for BVD, and a study conducted
in Florida by Knaizeff (1963) showed that 65 percent of beef cattle
and 61 percent of dairy cattle had BVD antibodies.

Seger (1968)

reported that 80 percent of samples from Louisiana cattle were
serologically positive for BVD.
similar results:

Other surveys of states revealed

59 percent in Illinois, 69 percent in Iowa and

73 percent in Nebraska (Newberne et al., 1961).
Kahrs et al. (1964) demonstrated positive neutralizing
antibodies for BVD in sera from White-tailed deer, while Richards
(1956) described a disease of White-tailed deer and Mule deer from
North Dakota in which the lesions were similar to those found in
cattle with BVD.

Pronghorn sheep have also been found to have BVD

antibodies (Barrett and Chambers, 1975).

BVD antibodies have also

been demonstrated in the sera of sheep and goats.

It has been

suggested that BVD virus can elicit an inapparent infection in
both species (Taylor et al., 1977a,b).

Domestic swine in the USA

can experience natural infection by the BVD virus.

However, no

apparent signs of illness are evident following BVD infection in
this species (Stewart et al., 1971; Carbrey et al., 1976).
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Characteristics of BVD Virus
Bovine viral diarrhea virus belongs to the family
Togaviridae which is presently divided into four genera.

Alphavirus

includes group A arboviruses and Flavivirus includes all group B
arboviruses.
viruses:

The other two genera consist of previously unclassified

Pestivirus and Rubivirus.

The Pestivirus genus includes

viruses closely related to hog cholera, and Rubivirus includes
rubella virus (Roberts and Carter, 1976).

Since the principal

nucleic acid in the BVD virus is ribonucleic acid it was termed an
RNA virus.

The RNA is single-stranded, present in one molecule and

has a molecular weight of 4 x 10^ daltons.

The BVD virus has a

cubical, capsidal symmetry with a configuration of 32 capsomers.
The virion has a characteristic envelope without an associated
transcriptase (Roberts and Carter, 1976).

The sedimentation coef

ficient of the virus particle is 80 to 90-S and its buoyant density
is 1.14 to 1.15 g per ml in a sucrose-density gradient (Fernelius,
1968).

Inactivation of the live virus can be accomplished with

chloroform and ether (Gillespie et al., 1963).

Chemotoxic sub

stances, such as 5-iodo-deoxyuridine and 5-bromo-deoxyuridine do
not inhibit growth of the Oregon strain of BVD (Hermodsson and Dinter,
1962).

The BVD virus is readily maintained in a lyophilized or frozen

state at -60 to -70 C for many years.

However, Gratzek (1961)

observed a 10-fold loss of virus viability in 24 hours at 26 C and
37 C.

In contrast, Coggins (unpublished data) found no apparent
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loss of viability of the Oregon strain of BVD virus following storage
at 25 C for 24 hours.

Electron micrographs of Oregon strain of BVD

virus, processed in chromium, demonstrated this virus to be rela
tively spherical and ranging in size from 35 to 55 nm (Pritchard,
1963).

Hermodsson and Dinter (1962) also found the virus particles

to be spherical and to measure approximately 40 nm.

In contrast,

three major size classes of BVD virus particles were observed by
Ritchie and Fernelius (1969) using phosphotungstic acid and electron
microscopy.

Maess and Reczko (1970) using ultracentrifugation, den-

sity-gradient centrifugation and rate zonal centrifugation in sucrose,
along with electron microscopy showed that the virion consists of
an envelope without projections and a nucleocapsid with cubical
symmetry.

They found the entire particle to be approximately 57 ±

7 nm with a core diameter of 24 ± 4 nm.

Millipore filtration studies

by Doyle (1933) and Fernelius (1968) indicated that the size of
viral particles were less than 50 nm which agreed with results
obtained using electron microscopy.

It is usually considered that

virus of the family Togaviridae range in size from 40 to 60 nm
(Roberts and Carter, 1976).

Virus Replication
Replication of most ribonucleic acid (RNA) viruses occurs
primarily in the cytoplasm of cells and is independent of nuclear
activity.

Exceptions to this general rule include orthomyxovirus

which require host deoxyribonucleic acid (DNA) transcription,
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paramyxoviruses which have a non-obligatory nuclear phase of
replication and retroviruses which replicate through a DNA inter
mediate (Goodheart, 1969).
The three steps in replication of RNA viruses consist of
(1) electrostatic interaction between the virus and specific cell
receptors,

(2) virus entering the cell by viropexis

(pinocytosis)

or by fusing with the cell membrane and (3) release of the viral
nucleic acid in the cytoplasm (Goodheart, 1969).
In general, replication of RNA is semi-conservative and
proceeds through a replicative intermediate (RI).

The RI consists

of the parental strand of viral RNA which serves as a template for
the transcription of several RNA strands.

These RNA strands

eventually "peel off" and serve as templates for the synthesis
of viral RNA (Goodheart, 1969; Roberts and Carter, 1979).
RNA molecules result in mature progeny

Viral

virions by encapsulation.

Subsequently, there is lysis of the host cell and release of viral
particles.

Olson et al. (1968) provided knowledge on the ability

of viruses to replicate within specific cell lines.

These workers

observed depression of lymphocyte reactivity after in vitro infec
tion with rubella virus.

Inhibition of protein synthesis was

observed and the possible mode of action was through the virus's
ability to synthesize new ribonucleic acid and block the ribosomal
sites on the lymphocyte.

Muscoplat et al. (1973) demonstrated that

the bovine viral diarrhea virus could inhibit mitosis induced by
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phytohemagglutinin of normal bovine lymphocytes cultured in vitro
with bovine fetal serum.

Pathogenicity of BVD
The first classification of BVD by Olafson et al. (1946) in
New York State was described initially as suspected feed poisoning
because of the gastro-enteritis and severe signs of diarrhea observed
in the disease.

Laboratory analysis of the feed was negative for

tests of toxicosis and led to a more precise documentation of the
signs of the new disease.

The involved animals were severely dehy

drated and epithelial erosion were found on the dental pad, palate
and lateral tongue surface, around the incisors and on the inside
of the cheeks.

Erosions were occasionally seen on the muzzle and at

the entrance of the nostrils.

Ulceration of the pharynx and larynx

and diffuse necrosis of the mucuos membranes of these regions
occurred in animals which later died (Olafson et al., 1946).
Present descriptions of clinical disease differs from
previous reports from the states of New York or Indiana.

In the

early reports, morbidity rates were high and cattle of all ages
were affected.

Earlier researchers suggested that most cattle

infected by BVD survived, but today the disease occurs sporadically
and frequently results in death of the animal (Kahrs, 1980).
The disease caused by the BVD virus generally affects
cattle between the ages of 6 to 24 months old but mature cattle
can also be affected.

In herds where acute cases were found,
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herdmates usually appear normal, but careful examination indicated
that subclinical disease was also present.

The typical case is

characterized by an elevated temperature, salivation, gingivitis
and erosions of the mucous membranes of the lips, gums and palate.
Diarrhea is not always present in the acute form of the disease, but
when present it is usually the cause of severe dehydration that may
lead to death.

Rapid respiratory rates and leukopenia are usually

observed in cattle experiencing BVD.

Acute laminitis with partial

alopecia and corneal opacity are occasionally observed (Kahrs, 1980).
The chronic form of the disease is most commonly known as
the mucosal disease syndrome.

Cattle with the chronic form of the

disease may appear as though they are recovering from an acute form,
but it can also occur without prior evidence of the disease in the
herd.

Infected cattle lose weight and become unthrifty.

mittent bouts of diarrhea are

observed

Inter

in affected animals.

Other

signs of chronic BVD infection include dry and scruffy skin, lame
ness, cracking or necrosis of skin in the interdigital spaces, and
erosions and necrosis around the coronary band.

Cattle experiencing

chronic BVD infection may have any of the lesions of the acute form.
These acute lesions may heal rapidly but can reappear throughout
the course of the disease, which can last for several months.

The

BVD virus can be isolated from samples of blood serum, ocular and
nasal secretions (Kahrs, 1980) and uterocervical secretions (Archbald,
1974) of chronically infected cattle.

These chronically infected

cattle fail to develop sufficient circulating antibodies and appear
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to be incapable of mounting an immunological response to the BVD
virus.

In extreme cases of chronic BVD infection the decline in

physical status results in death (Kahrs, 1980; Gillespie and Timoney,
1981), although most of these animals are culled from the herd.
Mild clinical BVD infection is characterized by fever and
leukopenia, both of which may affect cattle without detection.

The

disease in this form may be associated with increased respiratory
rate and a few scattered erosins of the oral mucosa or a few
reddened buccal papillae.

The mild signs of the disease are

usually not observed and therefore infection by the BVD virus may
not be apparent.

However a careful examination of the oral cavity

of animals with mild diarrhea and some sign of respiratory distress,
especially if these animals reside in herds where acute and chronic
BVD has been detected, will reveal reddened and blunted buccal
papillae.

Necropsy and further laboratory tests will usually pro

vide evidence of BVD infection.

It is this form of BVD that may

cause the greatest losses due to failure in reproduction (Kahrs,
1980).

Postvaccinal Reactions to BVD Vaccines
Bovine viral diarrhea vaccines have been commercially
available since 1964.

These vaccines utilize either the Oregon

C24 strain or the National Animal Disease Laboratory (NADL) strain
of the BVD virus.

Production of vaccines for use in interstate

commerce is regulated by the Veterinary Biological Service of the

Animal and Plant Health Inspection Services of the U.S. Department of
Agriculture (USDA, 1972).

To obtain the license for marketing and

distribution of a BVD vaccine the producer must demonstrate that the
vaccine is free of adventitious viral, mycoplasmal, bacterial and
mycotic agents (Lambert, 1973) and must pass a series of safety and
potency tests.
Careful monitoring of potency and safety of the BVD vaccines
is under the jurisdiction of the USDA at its specific agencies.
However, these specially controlled tests may be in vain if handling
of the product in the field is inappropriate.

Proper care and

storage of the vaccine before and during use are extremely important.
Direct sunlight and temperatures above 4C for prolonged periods can
inactivate the vaccine.

Therefore, proper refrigeration during field

conditions is essential to ensure optimal potency (Lambert, 1973).
All forms of the BVD infection can occasionally occur
following vaccination with modified live virus (MLV) vaccines.
Evidence of BVD infection usually occur 7-20 days postvaccination
in a very few cattle (Lambert and Fuller, 1970).

Clark (1968)

reported that 178 of 93,621 (0.19%) developed the clinical mucosal
disease syndrome about 13 days postvaccination.

The incidence of

postvaccinal reactions to BVD may be higher in individual herds due
to the health status of the cattle vaccinated.

The vaccination of

pregnant dams is not recommended since abortion and fetal damage
are common sequelae (Kendrick, 1971).

It is generally recommended
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that vaccination of open heifers and cows be done at least 30 days
prior to breeding or rebreeding (Lambert, 1973).
In order to prevent the occurrence of the reactions after
BVD vaccination in cattle, research was initiated to produce a safer
potent BVD vaccine.

Fernelius et al.

(1972) developed two methods

of inactivation of the BVD virus for subsequent vaccine production.
The Beta-propiolactone treatment inactivated the live virus while
retaining its high antigenic and immunogenic properties.

The

chloroform-treated vaccine developed by Fernelius et al. (1972)
exhibited good antigenic properties but its apparent immunogenic
properties were not as superior as the one prepared by inactivation
of the virus by Beta-propiolactone treatment.

Further research

proved that the vaccine produced by inactivation of the BVD virus
with Beta propiolactone resulted in a serviceable immunity level
and a second

inoculation 2 to 3 weeks later was beneficial in

increasing levels of circulating antibodies against the BVD
virus.

Recently, Fort Dodge Laboratories, Fort Dodge, Iowa has

introduced the first killed vaccine for BVD.

Triangle-1,'*' the new

inactivated BVD vaccine, will eliminate risks from post-vaccine
reactions which occur following use of live virus vaccines.
angle-1

R

Tri-

can be administered to pregnant cows, and eliminates the

necessity to isolate cattle after vaccination.
1

The recommended

R
Triangle-1 , Fort Dodge Laboratories, Fort Dodge, Iowa.
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vaccination program involves the use of Triangle-1

administered

in a single dose to animals previously vaccinated with one or another
MLV vaccine for BVD, followed by a booster dose once a year.

For

cattle never previously vaccinated for BVD, a two-dose series is
recommended, followed by an annual vaccination.

Diagnosis of BVD
The diagnosis of BVD is generally based on the demonstration
of signs and lesions characteristic of BVD.

The diagnosis can be

made on either the live animal or at necropsy.
Kahrs (1980) reported that the typical BVD infected carcass
is thin, dehydrated and usually has a scruffy hair coat soiled with
feces.

The infected animal may have erosions or ulcerations of the

mucous membranes of the oral cavity, esophagus, rumen and abomasum.
A characteristic finding is lymphoid depletion and hemorrhage or
necrosis of Peyer's patches.

Fatal cases of BVD may have necrotic

areas around the skin of the lower limbs, especially in the areas of
the coronary band.
Gillespie and Timoney (1981) emphasize that BVD can easily
be confused clinically with Malignant Catarrhal fever or Rinderpest.
They also noted that some bovine respiratory infections can be
confused with BVD.
Everman and Faris (1981) reported on current cases of BVD
infection from the northwestern section of the United States.

From
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the total of 74 cases, 60 cases were associated with classical
clinical signs of BVD infection.

There were 34 of 60 cases (57%)

that were observed with diarrhea, and 31 of 60 cases (52%) which
had respiratory tract involvement.

A small percentage of cases had

oral lesions (11%), ocular manifestations (10%) and abortion (5%).
Other reported clinical signs included enteritis without diarrhea,
blood in feces and epidermatitis.

Also reported were 11 cases of

mixed viral infection with BVD virus.

The dual infections included

bovine enterovirus (respiratory distress), parainfluenza type 3 virus
and bovine herepesvirus.

Similarly, Greig (1981) described a disease

outbreak in calves caused by a mixed infection with infectious bovine
rhinotracheitis (IBR) virus and BVD virus.

This severe outbreak of

disease had presented the classical signs of IBR infection with
lameness and marked alimentary tract involvement.
Since the clinical signs of BVD may not be apparent, diag
nosis should be confirmed with several laboratory tests.

At

necropsy, viral isolation tests can confirm BVD virus infection
from tissue samples of the spleen, lymph nodes or bone marrow.

In

the live animal, the virus can be isolated from blood, nasal or ocu
lar discharges (Kahrs, 1980).

Virus isolation techniques have been

outlined by Rovozzo and Burke (1973) which include basic tissue cul
ture techniques to determine cytopathogenic effect (CPE) in tissue
cultures.

Soto-Belloso et al.

(1976) developed a cell culture line

of bovine fetal endometrial cells and demonstrated its use in
determining cytopathogenic effects (CPE) of BVD virus.

After

three subpasses are made in cell culture without any cytopathogenic
changes, alternate tests are employed which can identify noncytopathogenic strains.

Some laboratories rely upon fluorescent

antibody tests (FAT) to determine the presence of BVD virus in
tissues.

Some problems exist when differentiating between Hog

Cholera Virus (HCV) and BVD since the fluorescent-antibody conjugate
detects both antigens.

Also, the preparation of reagents frequently

makes FAT an expensive diagnostic tool (Rovozzo and Burke, 1973).
Serological diagnosis is usually based on a serum neutra
lization test performed in cell cultures.

Rovozzo and Burke (1973)

described the serum-neutralization test as bringing the serum and
virus under specific conditions where

inoculation

into a suscep

tible host (animal, egg, tissue culture) could be illustrative of
the presence of antibodies.

If antibodies for the virus in question

were absent, disease, lesions or death might result to the host, or
when antibodies were present, no such reactions were noted.

Jensen

(1981) demonstrated the use of a serological test that had the
ability to differentiate between HCV and BVD.

He experimented with

three different methods for detection of antibodies from porcine
serum collected from swine during a low-virulent outbreak of hog
cholera in West Germany, as well as from a group of swine experi
mentally inoculated

with hog cholera virus and bovine viral diarrhea
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virus.

He found that serum neutralization tests using the peroxidase-

linked antibody could distinguish antibodies between HCV and BVD
with a high degree of reliability.

The use of serological diagnosis

of BVD as described by Kahrs (1980) can be more beneficial if paired
serum samples are taken, since there is a high prevailance of anti
bodies to the BVD virus from previous infection or vaccination of
most cattle populations.

Paired sera can be used to determine

seroconversion near the time of clinical disease.
The plaque technique as described by Singh (1969) and Rovozzo
and Burke (1973) can also be used in assaying BVD virus in vitro.
The plaque technique is based on the formation of plaques or foci
in or on various indicator systems.
infective particles:

Two methods exist for counting

end point (all or none response) and scoring

for growth or actual counting of foci.

The plaque technique is

considered to be a highly quantitative technique and has been used
for routine neutralization studies.

Using the plaque technique

distinct 3.5 mm plaques are identified 3 days following inocu
lation, as compared with 7 to 10 days which are required for final
reading of conventional CPE where liquid medium is used.

An

additional use of the plaque assay, as demonstrated by Roth et al.
(1981), was to purify the BVD isolate for later experimental studies.
Hopkinson (1979) developed a fast, simple and inexpensive
test for determining BVD serum antibodies using immunodiffusion
techniques.

This assay method had a high correlation to the
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standard virus neutralization test.

The latter is more expensive

and requires more time in obtaining final results.

However, the

sensitivity of the immunodiffusion test is somewhat less than that
of the virus-neutralization assay.
Muscoplat (1973) has demonstrated that in vitro lymphocyte
response can be utilized as a diagnostic test for BVD infection.
An interesting research note observed in his work was that the BVD
virus may alter the rate of deoxyribonucleic acid (DNA) synthesis
by the lymphocytes.

This important finding provided evidence to

support the theory that the immunosuppression observed in fatal
cases of BVD infection is possibly due to lymphocyte degradation.
Rapid diagnosis of virus diseases can be obtained by use
of the electron microscope (EM).

Gibbs et al. (1980) discussed the

flexibility and speed by which viral isolates can be identified
from clinical material on tissue culture with the electron micro
scope.

EM diagnosis of viruses can be based on the classification

of different families of viruses with sometimes different genera
whose characteristically different morphology allows simple identi
fication.

Specific techniques using EM for viral indentification

include negative staining with a heavy metal stain such as phosphotungstic acid, immunoelectron microscopy in which a viral antigen
is reacted with antibody, and finally thin sectioning.

Disadvan

tages of the use of the electron microscope in diagnosis of viral
diseases were that high concentration of the virus is needed for
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quantitative analysis and other tests for viral isolation must be
used to verify the presumptive nature of the test.

Transmission of BVD
Bovine virus diarrhea is considered a viremic disease and
secretions from acutely infected cattle contain virus.

Fecal

material, blood and splenic tissue are known vehicles for the
transmission of the disease (Gillespie and Timoney, 1981).

Roberts

and Carter (1976) reported that the mode of transmission is by
contact and fomites, and the avenue of infection is believed inges
tion.

Gillespie and Timoney (1981) suggest that sheep and goats

may play a role in transmission of the virus to cattle.
also occur as a natural infection in swine.

BVD can

Therefore, transmission

can theoretically occur with susceptible animals.

Wildlife, such

as deer, have been shown to possess BVD neutralizing antibodies.
This wildlife covers large areas of land and may be one reason for
the large population of cattle that have BVD antibodies (Richards,
et al., 1956; Carlson, et a l . , 1957; and Kahrs, et al., 1964).
Experimental transmission of BVD is usually accomplished by
oral drenching, intranasal or parenteral injection.
negative cows

inoculated

However, sero

in the uterus experienced seroconversion

(Lambert, 1969; Archbald, 1973; and Timoney, 1981).
Venereal transmission of the BVD virus has not been reported,
although the virus has been isolated from the urine of cattle pre
viously infected with the virus (McKercher, 1969).

Mills and
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Luginbuhl (1968), also reported isolation of BVD virus in urine
and renal tissue of experimentally-infected calves 2 weeks after
inoculation.

These workers have noted the possibility of the

shedding of the virus during copulation, thus suggesting venereal
transmission.

Whitmore et al.

(1978) have reported isolation of BVD

virus from experimentally-inoculated bulls.

From a total of 98

semen samples from nine bulls, four were found to harbor BVD virus.
The reproductive tracts from six of nine bulls were recovered and
BVD virus was isolated from a testicle of one bull.
study, Shultz et al.

In a more recent

(1982) reported data from viral screening of

40,000 ejaculates from bulls housed in an artificial insemination
(Al) cooperative.

The only virus that was found was BVD virus.

These studies suggest that the bull can shed BVD virus in semen.
Therefore, the bull theoretically, although unlikely, could transmit
the disease to the female during copulation or Al.

Relationship of BVD to Abortion in Cattle
The initial report of bovine viral diarrhea by Olafson
et al.

(1946) stated that 20 abortions occurred 10 days to 3

months after the outbreak of clinical signs of the disease.
This large variation in time from maternal infection to abortion
can lead to problems in accurate diagnosis of the disease.

Also,

BVD induced-abortion can occur in herds where BVD has never previously
been diagnosed.

Kendrick (1971) indicated that abortion occurred
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at a higher frequency when pregnant cows are infected early in
gestation, but abortion has been observed following infection at all
stages of fetal development (Kahrs et al., 1970a).
Clinical and epizootiologic observations of a dairy herd
in New York State showed that of 29 pregnant cows, 10 pregnancies
ended abnormally between 101 and 271 days of gestation.

Necropsy of

one fetus revealed abnormalities in the cerebellar folia of the
brain.

Serum antibody tests of pregnant cattle which do not abort

indicate positive antibody titers protect cattle from subsequent
reinfection and abortion.

Susceptible cattle, whose antibody titers

remain negative during a time of infection, usually become acutely
infected and abort if pregnant.

The high prevalance of BVD anti

bodies in cattle populations accounts for the low occurrence of
BVD-induced abortion with abortion storms due to BVD possible only
under rare circumstances (Kahrs and Ward, 1967).
The mechanism by which the BVD virus causes fetal death and
abortion are not clearly understood.

The BVD virus has been shown

to inhibit mitosis in lymphocytes stimulated by addition of
phytohemagglutinin (Muscoplat, 1973).

Olson (1968) demonstrated

that Rubella virus can also inhibit lymphocyte mitotic activity by
interference in blast transformation.

The Rubella virus is a RNA

virus of the Togavirus family and can cause spontaneous abortion,
stillbirth and cogenital abnormalities in humans.
In the study by von Benten (1980), Hog Cholera Virus (HCV),
which is another member of the Togavirus family, was experimentally

inoculated

into pregnant sows to demonstrate the ability of the

virus to cross the placenta membrane.

Fetal mortality was highest

at early gestational

inoculation

dates, and fetuses were found to

be viremic at birth.

It is suggested that BVD virus penetrates the

placental barrier during pregnancy and inhibits development of cells
undergoing mitotic cellular division (Archbald, 1979).

Margolis

et al. (1967) indicated that the external germinal layer of the
developing cerebellum represents a strategic area for cause of fetal
death by antimitotic agents such as viruses.

The lack of reparative

potential of these particular tissues has been noted as a cause of
the terminal destructive process.

Kahrs (1973) stated that the

outcome of fetal BVD infection is probably determined by factors
of chance, gestation age, the strain of virus and multiple unela
borated biological variables.

Approximately one of every 1000 bovine

pregnancies is wasted by BVD in the northeastern United States, but
these losses are not distributed normally throughout the entire
population of pregnant cattle (Kahrs, 1973).

Fetal Mummification and Resorption Due to BVD Infection
Fetal death during gestation results in termination of
pregnancy.

The outcome of the pregnancy is determined by the stage

of development of the fetus at the time of fetal death (Archbald,
1979).

Fetal death after 6 weeks of gestation usually results in

abortion, fetal maceration or mummification, whereas if fetal death
occurs prior to 6 weeks of gestation fetal resorbtion usually is
observed.
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Scott et al.

(1970) showed that fetal mummification occurred

when BVD virus was inoculated

in a heifer pregnant 107 days.

This

heifer was serologically negative for BVD antibody and serocon
version was noted at 8 days post-inoculation.

Leukopenia and a rise

in body temperature were observed following the inoculation

of virus.

Placental membranes were observed at 180 days post-inoculation
a mummified fetus was manually removed.

and

The estimated age of the

fetus upon removal was 135 days, and the time of fetal death was
calculated to be between 14 and 42 days.
Kendrick (1971) reported that experimental inoculation

of

23 pregnant cows of various gestation lengths resulted in one case
of a mummified fetus.

The mummified fetus in this study was removed

by cesarean section, after inoculation
of gestation.

of the virus on the 81st day

On the basis of fetal age determination upon removal

at 40 days post-inoculation

the approximate time of fetal death was

between 9 and 19 days post-inoculation.
Since BVD virus isolation techniques failed to demonstrate
BVD virus association with either case of mummified fetus, the possi
bility that a BVD virus infection caused fetal death can only be
circumstantial evidence.

Cases of mummified fetus are commonly

associated with uterine resorption of fetal membranes and fetal
fluids.

Archbald (1973) suggested that BVD infection of cows during

early pregnancy may cause fetal resorption.
Since the time sequence between estimated fetal death in cases
of mummified fetus coincided with the time of BVD infection, whether
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natural or experimental, the hypothesis that the BVD virus can cause
mummification in pregnant cattle is appropriate.

BVD Infection as a Cause of Infertility
The form of BVD infection that most commonly causes the vast
majority of reproductive failures is undiagnosed or unreported.
These inapparent BVD infections occurring in susceptible cattle
result in a biphasic temperature elevation and mild leukopenia.
Ovaritis, or inflammation of the ovary, has been indicative
of infertility in beef heifers.

Miller and Campbell (1978) reported

that 85 percent of 168 infertile heifers had lesions indicating some
type of inflammation.

Pregnant heifers were also found with ovaritis,

but the severity was not great as in the infertile heifers.

In an

attempt to diagnose the cause of the lesions, Summers et al. (1974)
showed no significant relationship of antibody titers to Brucella
abortus, Leptospira interrogans, serovars, pomona and hardjo;
Camplyobacter fetus or infectious bovine rhinotracheitis.

Ssentongo

(1980) processed ovaries from 368 infertile heifers from four herds
of which 78 percent of the cattle showed positive titers to BVD.

A

total of 12 BVD virus isolates were found from the ovarian emulsions.
One cytopathic virus isolate of BVD was inoculated at its first sub
passage into eight BVD antibody-free non-pregnant heifers.

Ovari

ectomy was performed after a 61 day period in order to observe
histological changes after infection.

All inoculated heifers

experienced seroconversion 15 days post-inoculation and a profuse
interstitial ovaritis was found in 100 percent of the heifers.

63

Direct intrauterine infusion of the BVD virus into cows at
estrus produced a localized infection of the uterus and uterine tube
(Archbald et al., 1973; Archbald and Zemjanis, 1977).
rates of cows inoculated

Pregnancy

with BVD virus prior to insemination at

12 hours post-estrus were lower (24%) than controls inoculated
with virus carrier vehicle and inseminated with identical semen (66%).
Similarly, BVD virus when added to semen caused a mild metritis in
inseminated heifers (Archbald et al., 1973).

A considerable number

of repeat-breeding animals have associated uterine infection, and
histopathological examination revealed a greater incidence of uterine
inflammatory changes in infertile than in fertile animals (Zemjanis,
1980).

Observations of superovulated donor cows with varying degrees

of endometritis indicated that uterine infection does not inhibit
fertilization rate of ova (Archbald, 1976).

It is recognized in the

studies by Archbald and Zemjanis (1977) that infertility was probably
caused by direct virus effect on the embryo or ova or indirectly by
the inflammation of the uterus.
It appears that BVD virus infections, whether acute, chronic
or sub-clinical, can affect reproductive efficiency at all stages of
reproduction.

Zemjanis (1974) has reported a high incidence of

embryonic mortality in two herds of cattle with histories of BVD
infections.

Lambert (1973) has indicated that a lowered conception

rate follows BVD vaccination with modified live virus vaccines.
Archbald (1973) has demonstrated that BVD serum-neutralization
antibody and the specific anti-BVD virus properties of uterocervical
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secretions are incapable of protecting the uterus and uterine tubes
after intrauterine inoculations
placement of the inoculum

of BVD virus.

Possibly direct

in the uterine lumen bypassed the natural

defense mechanism of the cervix (Archbald, 1973).

Edwards (1968)

showed that when serum neutralization antibodies are present in
high titers in the serum the transport may only be slight into
the uterus and uterine tube fluids.
In a later study, Archbald and Zemjanis (1977) demonstrated
that inoculation

of the uterine body and each uterine horn with

BVD virus followed by artificial insemination resulted in lowered
pregnancy rates.

Pregnancy rates for control cows was 66 percent,

compared to 24 percent for virus-inoculated

cows.

Viral isolations

were found, as reported by Archbald (1973) in uterine tissue.

This

finding supports the hypothesis that BVD positive serum titers and
uterocervical secretions with anti-BVD activity are incapable of pro
tection in the uterus and uterine tubes.

Inoculated uterine tissue

examination showed changes of focal mononuclear cell infiltration of
the submucosa and arteritis of the endometrium, but ulceration and
necrosis of epithelium of the uterus and uterine tube were not
observed in tissues from which BVD virus was isolated.

Suggested

explanations of the lowered pregnancy rates were suggested as
being (1) a result of impaired fertilization by areas in the uterus
of localized infection or (2) the virus inoculation

caused death of

the developing embryo via localized infection or (3) direct virus
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action on the embryo.

Since the non-pregnant inoculated

cows

returned to estrus with no alteration or extension of previous
estrous cycle lengths, it was assumed the embryo was affected in
some manner prior to maternal recognition of pregnancy.
More supportive evidence that the virus infection may impede
ova or embryonic development prior to maternal recognition of preg
nancy was demonstrated by Archbald (1977).

BVD virus was quantified

by virus isolation procedures from the uterocervical secretions of
a cow which had failed to conceive after repeated attempts of
artificial insemination.

Subsequent estrous cycles were regular

and consistent and the suggested cause for this repeat-breeder
syndrome was embryonic death or lack of fertilization.

This cow

was detected from a herd of Holsteins which experienced abor
tions, fetal mummification and infertility apparently caused by
clinical BVD infections.

According to Archbald (personal communi

cation) , BVD virus does not interfere with fertilization but may cause
embryonic death between eight and sixteen days after breeding.

Congenital Defects of Calves Following BVD Infection
Bovine viral diarrhea (BVD) infection of susceptible pregnant
cattle can be followed by normal calving, or by abortion, still
births, mummified fetuses or birth of calves with various congenital
defects (Kahrs, 1973).
One of the most common congenital defects caused by in utero
BVD infection is cerebellar hypoplasia (Ward, 1969; Ward et al., 1969;
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Kahrs, 1970; Kahrs et a l . , 1970a; Kahrs et al., 1970b; Brown et al.,
1973; and Scott et al., 1973).

The cerebellar hypoplasia defects of

newborn calves are characterized by neurologic defects varying from
slight ataxia to complete inability to stand even though these
calves usually have normal muscle tone and strength.

Severely

affected calves that are unable to stand usually assume abnormal
positions.

Head tumors and nystagmus are also frequently observed

in calves suffering from cerebellar hypoplasia.
calves show only remnants of the cerebellum.

Necropsy of these

Usually a fluid-filled

space covered by meninges are found instead of the cerebellum.

His

tological examination usually reveals severe depletion of granule
cells with clumping of the remaining cells and ectopia of Purkinje
cells.
Ocular lesions are also commonly associated with congenital
BVD infections but may not occur in the same calf with cerebellar
defects (Kahrs, 1980).

Bistner et al. (1970) described the histo

logical changes of ocular defects from calves of dams either naturally
or experimentally infected with BVD virus.

Calves born to cows

experimentally infected with BVD virus had ocular abnormalities
consisting of retinal atrophy, optic neuritis, cataract and micro
phthalmia with retinal dysplasia.

Retinal lesions were also seen

in the calves from naturally-infected cows.
Congenital hydrocephalus in calves has also been associated
with in utero BVD infections (Markinson, et al., 1976; Axthelm and
Leipold, 1980; Badman et al., 1981).

The principal central nervous
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system malformation associated with BVD infection is cerebellar
hypoplasia, but Ward (1971) observed that inoculation

of BVD virus

into pregnant sheep on days 22 and 47 of gestation produced lambs
with hydrocephalus.

Hydrocephalic calves have associated cerebellar

hypoplasia (Badman, 1981) but cerebellar hypoplasia can be observed
without hydrocephalic defects.
The BVD virus has also been incriminated in other congenital
defects not associated with the central nervous system.

Scott et al.

(1973) observed brachygnathism of the mandible in calves from
BVD-infected dams, while Gratzek (1968) demonstrated musculo
skeletal deformities of calves associated with BVD infections.
Calves with partial alopecia have also been observed after in utero
BVD infections (Kendrick, 1971).

Viral Infections of Mammalian Preimplantation Embryos
The interaction of the mammalian embryo with viruses is an
important area of investigation since viruses are known to exist in
the genital tract (Christian et a l., 1965; Virgilio et al., 1965).
Certain viruses are also known to produce specific congenital defects
in mammals (Blattner and Heys, 1961; Evans and Brown, 1963; Gordon
et al., 1964; Medearis, 1964; Ferm and Kilham, 1965; Hardy, 1965;
Stoller and Colemann, 1965; Williamson et al., 1965; Brown et al.,
1973).
Several investigators have provided ultrastructural evidence
for the presence of natural oncornaviruses (A- and C-type particles)
in preimplantation embryos (Enders and Schlafke, 1965; Anderson and
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Jeppesen, 1972; Chase and Piko, 1973; Kalter et al., 1974a,b).
Farther investigation of the interactions of some types of virus
with the preimplantation embryo has revealed that virus like par
ticles could only be observed in the inner cell mass and not in
the trophoblast cells (Biczysko et al., 1973).

In contrast, Glass

et al. (1974) injected Newcastle disease virus directly into the
mouse blastocyst and found large numbers of pleomorphic viral forms
to be present in the trophoblast while the inner cell mass did not
show evidence of viral infection.

Another important finding by

Chase and Piko (1973) was that an embryo stage dependency was deter
mined in the number of virus particles observed in embryos.

Viruses

were not observed in one-cell fertilized oocytes, but were present
in embryos from the two-cell to blastocyst stage.

This phenomenon

may be attributed to the onset of ribosomal RNA synthesis which is
initiated at the fertilized one-cell stage (Calarco and Szollosi,
1973).
The natural significance of oncornavirus particles in germ
cells and preimplantation embryos is not well understood, but does
seem to indicate vertical transmission, via either the female or
male gametes (Bowen, 1979).

Evidence of the vertical transmission

of virus from mother to young is reported by Tuffrey et al. (1972).
Embryos recovered from mice within a colony of mice in which Sendai
virus infection was endemic were frequently degenerate; whereas,
embryos from an adjacent colony which was free of Sendai infection
were normal.

Another report of virus which can apparently cause
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natural infection of preimplantation embryos is lymphocytic
choriomeningitis virus.

Mims (1966) has demonstrated that infected

mice harbor the virus in essentially all cells, including the gonads,
and the viral antigen has been identified in the cumulus cells and
in some mature oocytes.

The exact mechanism for vertical trans

mission has not been determined, but previous evidence indicates
that oocytes are infected prior to ovulation.
Gwatkin (1963) first reported the experimentally-induced
viral infection of a mammalian preimplantation embryo.

He noted

that in vitro exposure of two-cell mouse embryos to Mengo encepha
litis virus significantly decreased the number of embryos which
developed to blastocysts.

In that study, the zona pellucida was

not an effective barrier to the virus, contrary to the postulation
by Austin and Lovelock (1958).

Antiserum against the Mengo virus

added to the virus suspension prior to in vitro incubation with
embryos completely prevented the inhibitory action of the virus on
the development of the embryos (Gwatkin, 1963).

Gwatkin (1964)

showed that Mengo encephalitis virus was actually replicating in
the embryos after exposure to the virus in vitro.

He also pointed

out that virus penetration of the zona pellucida was complete within
10

minutes or less and virus synthesis was also found to occur in

the unfertilized ovum.
The interaction of oncogenic deoxyribonucleic acid (DNA)
viruses with preimplantation embryos has been studied by several
investigators.

Brackett et al. (1971) found that although intact
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Simian virus 40 (SMV40) did not absorb to rabbit spermatozoa, isolated
SVM40 DNA was taken up by spermatozoa.

The failure to remove this

DNA after treatment with deoxyribonuclease indicated that the viral
genome was probably internalized in some manner by the sperm and
not merely absorbed on the surface.

Does were inseminated with

spermatozoa exposed to SMV40 DNA and fertilized embryos were recovered.
Cocultivation of these ova
the infectious virus.

with cell

Baranska et al.

cultures allowed recovery of
(1971) using similar tech

niques, found infectious SMV40 virus or SVM40 DNA could be recovered
from previously exposed unfertilized ova, two-cell embryos and
of mice.

Biczysko et al.

(1973) exposed two-cell mouse embryos,

blastocysts and egg cylinders to SMV40 and Polyoma viruses.

Uptake

of SMV40 but not Polyoma virus was found in two-cell embryos, while
blastocysts and egg cylinders were found to absorb and take up both
viruses.

Replication of Polyoma and SMV40 observed by electron

microscopy was observed in all stages of embryos and the mechanism for
uptake in all embryos was by endocytosis.

The zona pellucida did

effectively prevent penetration by both viruses in this study.
Viral infections of early embryos can be experimentally
induced in vitro or in vivo by exposure of embryos to virus.
Neighbors (1978a) utilized both techniques in studies on the susceptability of the mouse preimplantation embryo to infection with
Cytomegalovirus.

The preimplantation embryos exposed to Cytomegalo

virus in vitro developed normally to the blastocyst stage and there
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was no evidence of embryonic infection.

Intraperitoneal inocula

tion of female mice with this virus produced an acute generalized
infection, and embryonic development was retarded in v ivo.

The

embryos from in vivo infected mice developed into normal fetuses
when transferred to uninfected mice.

The failure to infect early

mouse embryos by either in vitro or in vivo techniques with Cyto
megalovirus indicates some indirect consequences of the maternal
disease.

Neighbor (1977) showed that acute, localized Cytomegalovirus

infection of the uterus, induced by intrauterine inoculation of the
virus on the day of mating, also retarded preimplantation develop
ment without causing productive embryonic infection.

In another

study by Neighbors (1978b), Cytomegalovirus excreted in semen of
infected male mice did not produce a productive infection in pre
implantation embryos when added to an in vitro fertilization system.
Research input concerning virus interactions upon bovine
preimplantation embryos are limited.

Archbald et al. (1979) inocu

lated the right uterine horn of five Holstein cows 7 days after
artificial insemination with BVD virus.
days post-inoculation

from infected

Embryos collected

3

uterine horns were degnerate.

Electron microscopic examination of the degenerative embryos from
the infected uterine horns demonstrated the presence of a structure
which morphologically resembled the BVD virus.

Preliminary results

indicated that the presence of BVD virus within the uterine horns
may interfere with normal development of preimplantation bovine
embryos.
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Embryo Transfer as Technique for Controlling Transmission of Viral
Diseases
Embryo transfer is now a recognized procedure in cattle, pigs,
sheep, goats and horses (Betteridge, 1977).

Generally used in com

bination with superovulation, embryo transfer has been promoted as a
means of genetic improvement, introducing new bloodlines into closed
herds, obtaining offspring from infertile female animals and conduc
ting research in all species.

Relatively little attention has been

given to the potential role of embryo transfer in the control of
infectious diseases.

However, it has been recommended as a useful

technique for the rapid establishment of minimal disease herds from
a few animals with superior genetic backgrounds, or the introduction
of disease free animals with a different genetic background into
established minimal disease or closed herds (Curnock et al., 1976).
The collection of uninfected embryos from infected parents
for transfer to uninfected recipients would be one approach to the
control of infectious diseases (Eaglesome et al., 1980).

Normally,

when a particular disease is endemic on a farm and the farmer decides
to eliminate the disease from his herd, the recommendation would be
to slaughter the animals, disinfect the premises and restock with
disease free animals.

This approach would involve the loss of val

uable blood lines and years of work.

If it could be shown that the

etiological agent is not transmitted from either parent to the embryo,
a different approach such as embryo transfer with superovulation
might offer a workable, more economically rational alternative.
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Waters (1981) has suggested several techniques for processing
of embryos for health certification of livestock.

Techniques indi

cated were health certification of the genetic sire, and dam,
transfer procedure, transport medium as well as a health certification
of the recipient following implantation before embryos can be trans
ported internationally.

The United States Department of Agriculture

(USDA) has not established specific standards for disease control for
exportation of embryos from the United States, with only the require
ments for disease prevention

standards of the importing country must

be met prior to shipment.
Experimentation on the effect of virus interaction with
mammalian embryos is mainly limited to laboratory animals and swine.
Wrathall and Mengeling (1979a,b) indicated that porcine parvovirus
significantly lowered in vitro development of pig embryos exposed
to virus, and virus was identified on the periphery of the zona
pellucida of infected embryos.

When parvovirus-exposed embryos

were transferred to seronegative gilts for 8 days and subsequently
recovered, embryonic retardation was evident and the recipient gilts
seroconverted to positive status.

Further research by Wrathall and

Mengeling (1979b) showed that the probable reason for embryo retar
dation was uterine damage, which was considered a direct result of
the parvovirus infection.
Another experimental use of embryo transfer to control
disease transmission was demonstrated by Bolin et al. (1981).

Embryos were experimentally infected with pseudorabies virus both
in vitro and in vivo.

Serologic evidence of pseudorabies virus

transmission was found in recipients in both in vitro and in vivo
exposed embryos, but pigs born to recipients did not show evidence
of exposure to pseudorabies by serologic testing or fluorescent
antibody procedures.
Evidence of disease transmission in cattle by embryo trans
fer is non-existent, but limited in vitro studies may illustrate
this possibility.

Voelkel et al.

(1982) attempted to isolate Brucella

abortus from uterine flushing of brucella-infected donor cattle.

In

that study, Brucella abortus inoculated in the uterus could not be
recovered in later uterine flushings, embryo holding medium or the
harvested embryos.

Singh et al.

(1982a) evaluated the effects of

Akabane, Bluetongue and Bovine Viral Diarrhea (BVD) virus upon pre
implantation bovine embryos.

After virus exposure, embryos were

cultured jin vitro for 24-48 h and results indicated that embryonic
development was not affected in any groups.

Also, no infectious

virus was isolated from any of the embryos.

In addition, embryos

and ova isolated from donors that were seropositive to BVD virus
were found uninfected with the virus.

Immunoglobulins found in

follicular fluid by Whitmore and Archbald (1977) may provide some
protection for recently ovulated ova.

Because of the protection of

immunoglobulins, embryo transfer was suggested as a means of con
trolling the transmission of the viral infections.

In later research,
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infectious bovine rhinotracheitis (IBRV) was evaluated in vitro with
bovine preimplantation embryos (Singh et al., 1982b).

IBRV was found

to have no effect on embryonic development in vitro.

Embryos and ova

isolated from donors seropositive to IBRV were found to be uninfected
with this virus.
At the present time, there are no guidelines as to which
agents can be transmitted from parent to offspring either through
the gametes or from the environment.

Before existing regulations for

the control of disease in the international movement of embryos can
be relaxed on the sire, dam and herd of origin and before embryo
transfer can be used as a means to control or eliminate disease in
a herd or flock, the etiological agent of each disease of concern
will have to be investigated individually.

Before embryos can be

certified virus free, it must be determined whether the agent in
question is capable of being transmitted by the zona pellucida-intact
embryo.

Embryo transfer can only be used as a means of controlling

or eliminating disease if it can be shown that the holding medium or
embryo itself are not carriers and that the organism will not infect
the potential recipient animal.

CHAPTER II

IN VITRO CULTURE OF BOVINE VIRAL DIARRHEA (BVD)
VIRUS AND LIVE AND DEAD BOVINE EMBRYOS WITH AND
WITHOUT AN INTACT ZONA PELLUCIDA: A TRANSMISSION
ELECTRON MICROSCOPIC STUDY

Introduction
Electron microscopy has provided a wealth of valuable infor
mation relevant to the field of virology.

Until the first electron

micrographs of viruses were obtained in 1939, nothing was known about
the structure of virus particles.

Lwoff, Horne and Tournier (1966)

proposed a system of virus classification (the LHT system) based on
the type of nucleic acid contained in the virion.

The remaining

criteria for classification were related to observations using highresolution transmission electron microscopy (TEM).

The four charac

teristics of the LHT system were:
(1)

The chemical nature of the genetic material, either DNA
or RNA, which determined the Subphyla.

(2)

The

symmetry of the nucleocapsid of the virion:

helical,

cubic or binal, which determined the Class.
(3)

The

covering of the nucleocapsid, whether naked or

enveloped, which determined the Order.
(4)

The

size of the nucleocapsid, either the diameter of

the helix, or the number of capsomers in the cubic
system, which determined the Family.
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The ultrastructure of the bovine viral diarrhea (BVD) virus
can

beidentified by electron microscopy as being from the Togaviridae

family (Palmer and Martin, 1982).

BVD is an RNA virus.

one molecule of a single strand of

RNA.

morphology and ranges in size from

40 to 70 nm.

It contains

BVD virus has a spherical
A lipoprotein

envelope is found tightly attached to an icosahedral nucleocapsid
with a total of 32 capsomers each about 14 nm in diameter.

The

estimated molecular weight of the nucleus of a single BVD virus
particle is 4 x 10^ daltons (Roberts and Carter, 1976).
TEM also has applications in the rapid diagnosis of virus
diseases

(Gibbs et al., 1980).

divided into two stages:

The methodology for such use is

(1) demonstrating virus in clinical

material or (2) identifying isolates from tissue culture or similar
systems.

Utilization of TEM in the diagnosis of skin infections

caused by viruses (small pox:

Nagington and Macre, 1965), brain

biopsies of patients with herpesvirus encephalitis

(Gardner, 1977)

and in the nasophayngeal secretion

of children and horses with

respiratory disease (Doane et al.,

1967) are a few examples of the

flexibility TEM offers in the diagnosis of viral diseases.
The use of TEM for the study of cell structure in mam
malian preimplantation embryos led to the intriguing and perplexing
observations of cytoplasmic particles that closely resembled virus
particles.

These natural occuring infections were initially observed

by Calarco and Szollosi (1973) and aroused considerable attention as
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the involvement of vertical transmission of viruses.

Initial demon

strations of these virus-like particles were found in ova and embryos
of the mouse (Calarco and Szollosi, 1973), rabbits (Manes, 1973),
non-human primates (Kalter et al., 1974b) and humans (Kalter et al.,
1973).
The use of TEM has benefited experimental studies utilizing
in vitro virus infection of mammalian embryo culture systems.
Bicsysko et al.

(1973) demonstrated tissue specificity to various

viruses and uptake of newly synthesized viruses by specific cell
types.
Although the utilization of TEM for research in virology
has great advantages, the technique has obvious disadvantages.
Gibbs et al.

(1980) reported two disadvantages of the use of TEM

as a diagnostic tool in viral infection:

(1) high virus particle

concentration is needed and (2) the presumptive nature of the assay.
The extremely small size of the virus particle (% 30-50 nm) poses
a limitation on the resolving power, and assumed virus particles
found in specimens are routinely called

"virus-like" particles.

More quantitative tests are usually utilized for more accurate
diagnosis of viral infection; for example,conventional virus
isolation and immunocytochemical techniques.
The objectives of this experiment were:
1.

To demonstrate the presence of the BVD virus in bovine
embryos following in vitro incubation using TEM and
virus isolation techniques.
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2.

To evaluate the affinity of BVD virus for live and dead
bovine embryos.

3.

To evaluate the ability of the zona pellucida to afford
protection to the embryo from BVD virus particle
penetration.
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Materials and Methods
Experimental Embryos.

A total of 80 bovine embryos were

collected from crossbred Angus, Hereford and Brahman donor cows
superovulated with 40-45 mg of follicle-stimulating hormone"*"^ (FSH)
administered intramuscularly (IM) in 5 mg injections twice daily
for 4 days.

Treatment with FSH began between days 8 and 12 of the

estrous cycle (estrus = day 0).
19

of prostaglandin F

Prostaglandin F„

Ia

18

, or an analogue

, was administered at dose levels of 35 mg and

2a
500 pg, respectively, at 48 hours after the initial FSH injection
and estrus was expected within 2 days of the injection of the
luteolytic agent.

Donors were inseminated with frozen-thawed semen

from bulls that were seronegative for BVD and embryos were collected
non-surgically on days 6.5 to 7.5 following the induced estrus.
The flushing medium utilized in this project was Dulbecco's PBS
with 2 percent FCS with standard levels of antibiotics and antimycotic
(appendix table 2).

Embryos were morphologically classified at 100 X

magnification using phase-contrast optics and morphological grading
scores were assessed.

The FDA viability test was utilized to assess

viability of the embryos.

Fluorescence scores of embryos greater

than 0 were considered live and viable in this experiment.
17
18

Embryos

R
FSH-P , Burns-Biotec, Omaha, Nebraska.
Lutalyse

R

(dinoprost tromethamine), Upjohn, Co., Kalamazoo,

Michigan.
19

R
Estrumate
(cloprostenol sodium), Haver-Lockhart, Bayvet
Division Cutter Laboratories, Inc., Shawnee, Kansas.
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were assigned to four equal treatment groups (20 embryos per treat
ment).

These groups were as follows:

zona pellucida,

(1) Live embryos with an intact

(2) Live embryos without a zona pellucida,

(3) Dead

embryos with an intact zona pellucida and (4) Dead embryos without a
zona pellucida.
Zona pellucidae were removed by micro-dissection using a
Leitz micromanipulator

20

fitted with left- and right-handed controls.

Micro-dissection techniques were employed in a lid of a 100 mm petridish filled with Dulbecco's PBS supplemented with 10 percent goat
serum, antibiotics and an antimycotic (appendix table 4).

Goat serum

(GS) was selected as a portein source for embryos to eliminate the
possibility of unknown contamination with BVD virus neutralizing anti
bodies in bovine serum (Waters, 1981).

Micro-dissection techniques

were performed under stereomicroscopsy at a magnification of 75 X
utilizing micro-instruments constructed from glass pipettes.

This

technique enabled removal of the zona pellucida without inflicting
damage to the cellular mass.
Exposure of Embryos to BVD Virus.

Embryos from each treat

ment group were cultured In vitro with BVD virus in one volume of
Dulbecco's PBS supplemented with 10 percent GS and one volume of
Minimum Essential Medium (MEM) containing the BVD virus (appendix
table 4).

20

The BVD virus (Singer Strain, Lot 4) was originally

Leitz Micromanipulator, E. Leitz, Wetzlar, Germany.
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obtained from the USDA National Veterinary Services Laboratory,
(NVSL) Ames, Iowa.

The virus was passed once through BVD-free bovine

turbinate cells, which was also obtained from USDA-NVDL, and grown in
goat serum-enriched MEM.

The titer of the stock virus was 10

Tissue Culture Infective Dose - 50(TCID^^).

4

- 10

5

This titer indicated

that the BVD virus suspension, diluted to 10-^ to 10 ^ and inoculated
in units of .025 ml, is the highest dilution which infected 50 percent
of the tissue culture system.

Embryos were cultured in a 2 ml volume

in 35 x 10 mm tissue culture dishes for 24 hours at a constant tem
perature of 37 C in a humidified air atmosphere.

Immediately after

the 24 hour culture period, the embryos were washed by transferring
them through three 2 ml volumes of Dulbecco's PBS with 10 percent GS
(1:400 dilution).

A fresh handling pipette was used to transfer the

embryos to each successive wash.

After washing, the embryos were

assessed as to their morphological classification, morphological
grade and fluorescence score.
Processing of Embryos for T EM.

Immediately following post

culture evaluation, 40 embryos (10 embryos per treatment) were ran
domly selected for electron microscopic evaluation.

Embryos were

pre-fixed for 1 hour in 3 percent glutaldehyde in .1 M sodium
phosphate buffer and then washed three consecutive times in .1 M
phosphate buffer and left in the final wash at 5 C until further
processing (appendix table 5).

A total of five grids, each with 5-10

sections from each embryo were evaluated.

Demonstrative comparisons
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presented in pictorial form for each treatment group provided ultrastructural differences and alterations in the specific location of
"virus-like" particles.
Processing of Embryos for Viral Assays.

Immediately following

post-culture evaluation, the remaining 40 embryos (10 embryos per
treatment) were sonificated using a high frequency sonifer
replicates of three to four embryos.
for each treatment group.

21

in

Three replicates were assayed

The sonificated embryos, the BVD virus

inoculum in which the embryos were cultured, the medium in which the
embryos were initially washed and a control inoculum in which no
embryos were cultured, were all subjected to virus isolation pro
cedures (appendix table 6) and verified by fluorescent antibody
assay (appendix table 7); as described by Rovozzo and Burke,
and Fulton et al.,

(1982).

(1973),

Samples indicating positive cytopathic

effects (CPE) were validated as positive for BVD virus with the
fluorescent antibody technique.

Viral isolation procedures were

initially completed on the medium from the first washing of the
embryos.

If this medium was positive, the second and third washes

were subsequently assayed.

Virus concentration titrations (appendix

table 8) of control inoculum and the inoculum containing the BVD
virus in which the embryos were cultured were assayed in order to
assess levels of the uptake of virus among the treatment groups.
21

Branson Sonifer, Model-200, Danbury, Connecticut.
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Statistical Analysis.

Differences in mean values for

live embryos with an intact zona pellucida and live embryos without
a zona pellucida for pre-culture and post-culture assessments of
morphological grades and fluorescence scores were analyzed by Stu
dents t-test procedure (Steel and Torrie, 1980).

The number of

embryos developing in culture for each treatment group were compared
by Chi-square analysis.
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Results and Discussion
Mean values for pre- and post-culture viability indicators
and percent development of all four treatments groups of embryos are
shown in table 18.

Pre-culture morphological grades and fluorescence

scores were similar and not significantly different for live embryos
with and without the zona pellucida.

Unfertilized ova were utilized

in each treatment group for dead embryos with and without zona pellu
cida, which accounted for pre-culture morphological grades and
fluorescence scores of zero.

Post-culture morphological grades of

live embryos with and without a zona pellucida were increased when
compared to corresponding pre-culture assessments, indicating decreased
viability.

Although, no significant differences were found for post

culture morphological grade between live embryos with a zona pellucida
and live embryos without a zona pellucida.

Post-culture fluorescence

scores of live embryos with and without a zona pellucida were decrea
sed when compared with pre-culture fluorescence scores, indicating
decreased viability.

These results are in general agreement with

those of Chapter I, as culture time was a major source of variation
in morphological grading and fluorescence scores.

Post-culture

fluorescence scores of live embryos with intact zona pellucida
were higher than scores of live embryos without zona pellucida, sug
gesting increased viability.
significantly different.

However, this difference was not

Post-culture morphological grades and

fluorescence scores of dead embryos with and without zona pellucida
remained unchanged indicating advanced degeneration and no viability.

TABLE 18.

MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS
AND PERCENT DEVELOPMENT OF LIVE AND DEAD EMBRYOS WITH
AND WITHOUT AN INTACT ZONA PELLUCIDA1

Pre--culture
Grade Fluorescence

Post -culture
Grade Fluorescence

No. of embryos developing
in vitro

Treatment group

n

% Developing

Live embryos
with a zona
pellucida

20

1.65a
+ .19

3.18
+ .26

2.00
+ .19

1.23

15

75%

Live embryos
without a zona
pellucida

20

1.65
+. 16

3.05
+ .14

2.05
+ .26

.63
+.09

14

70%

Student's t-test used to test differences among means,
^ e a n plus or minus standard error.

oo
CTi
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A total of 15 of 20 (75%) live embryos with an intact zona
pellucida developed in BVD virus-infected medium after 24 hours,
while 14 of 20 (70%) of live embryos without a zona pellucida
developed

in culture.

Although live

pellucida

developed at a lowered rate

embryos without a zona
than live embryos with an

intact zona pellucida, this difference was not significantly dif
ferent.

These data indicate that embryonic development within the

BVD virus-infected medium defined was independent of the intact
zona pellucida.
technique

Recently, Bowen et al. (1982) utilized a similar

(removal of zona pellucida) of bovine embryos to study

the effect of Bluetongue virus upon embryonic development.

This

study showed that the zona pellucida protected the virus-exposed
embryos while the zona pellucida free embryos degenerated.
Results of virus isolation, fluorescent antibody and virus
titration assays of control and BVD virus-infected medium and embryos
are shown in table 19.

Virus isolation procedures were negative for

sonificated embryos of each treatment group, along with the initial
wash samples of each of the embryo treatment groups.

Singh et al.

(1982a) found similar results with viral isolation assays of BVD
virus exposed embryos.

Possible explanation for these negative

assays of sonificated embryos, are offered by Bowen (1979).

He

indicated that due to the very small size of mammalian preimplan
tation embryos the use of conventional virus isolation assays
utilizing cell culture may have some definite inadequacies.

The

TABLE 19.

Treatment group

RESULTS OF VIRUS ISOLATION, FLUORESCENT ANTIBODY AND VIRUS
TITRATION ASSAYS OF CONTROL AND BVD INFECTED MEDIUM AND
EMBRYOS

Sonificated
Embryos

Initial
Wash

_a

__

-

--

Control BVD
Medium

Control BVD Medium
With Embryos
1 33

Difference

+b ; 10 lc

+ ; 10

+; 1 0 1

+ ; 101

0

Dead embryos
with a zona
pellucida

+; 1 0 1-33

+; 101

.33

Dead embryos
without a zona
pellucida

+; 101-33

+; 10l

.33

Live embryos
with a zona
Live embryos
without a zona
pellucida

-.33

aNegative CPE on virus isolation assay.
^Positive CPE and positive on fluorescent antibody assay.
cTissue Culture Infective Dose - 50 (TCID 50^

CD
00
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possibility that the BVD virus upon interaction with bovine embryos
were rendered non-infective or that the c.ytopathic effect of the
virus has changed to a non-cytopathic effect cannot be established
in the experiment by Singh et al.

(1982a) or the present experiment.

The change of cytopathic effect of BVD virus has been shown in swine
by Stewart et al.

(1971) and Carbrey et al.

(1976), while the non

permissiveness of viruses to mammalian embryos has been reported by
Neighbour (1978a) and Biczysko et al.

(1973).

Attempts to quantitate the uptake of virus by performing
BVD virus titration assays on control medium (without embryos) and
BVD virus medium with embryos was unsuccessful in the present experi
ment.

FA tests confirmed active virus in all control and embryo

cultured medium after the 24-hour culture period, although only
small and inconsistent differences in virus titrations were found
between control and virus medium with embryos.
TEM evaluation of embryos in each embryo treatment group
provided new information as to ultrastructural differences between
live and dead embryos, each with or without a zona pellucida.

Struc

tures which morphologically resembled the BVD virus were found in
live embryos with an intact zona pellucida (figures 1, 2 and 3).
Virus-like particles were found at a greater incidence within the
cytoplasm of trophoblast cells of blastocysts with an intact zona
pellucida.

The presence of these virus particles provided evidence

that the BVD virus can penetrate the zona pellucida of bovine embryos.
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Figure 1. A transmission electron micrograph of a section
from a live embryo with an intact zona pellucida.
The presence of
mitochrondria (M) within the cytoplasm of this trophoblast cell
may indicate viability in presence of a virus-like structure (arrow)
that morphologically resembles the BVD virus.
Uranyl acetate and
lead citrate stain; 96,000 X.
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Figure 2. A transmission electron micrograph of a section
from a live embryo with an intact zona pellucida showing microvilli
(Mv) and presence of a BVD virus-like structure (arrow). Uranyl
acetate and lead citrate stain; 96,000 X.
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Figure 3. A transmission electron micrograph of a section
from a live embryo with intact zona pellucida.
Endoplasmic
reticulum (ER) in the cytoplasm of a trophoblast cell along with
the presence of a BVD virus-like particle (arrow). Uranyl acetate
and lead citrate stain; 96,000 X.
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Archbald et al.

(1979) demonstrated the presence of a structure

which morphologically resembled the BVD virus from a zona pellucidaintact degenerate embryo which was collected after in utero inocu
lation with medium containing BVD virus.

The presence of the BVD

virus beneath the zona pellucida is in disagreement with data of
Singh et al.

(1982a) which suggested that the BVD virus was not

capable of penetrating the zona pellucida.
that the observations of Singh et al.

It is important to note

(1982a) were not made by elec

tron microscopy, but by virus isolation assay.

This discrepancy may

be due to the fact that the small amounts of viral particles which
penetrated the zona pellucida was below the limit of detection of
the virus assay.
Figure 4 depicts a virus-like particle that resembles the
BVD virus within the inner cell mass of a live embryo without a
zona pellucida.

The presence of this virus particle demonstrated

that the BVD virus may have no tissue specificity as to infection
of bovine embryos.

Biczysko et al.

(1973) reported that virus-like

particles could only be observed in the inner cell mass and not in
the trophoblast cells, while Glass et al.

(1974) using Newcastle

disease virus found no virus in the inner cell mass although eval
uation of the trophoblast revealed the virus.
BVD virus-like particles were also observed in other live
embryos without a zona pellucida within the cytoplasm of a tropho
blast cell (figure 5).
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Figure 4. A transmission electron micrograph of a section
from a live embryo without a zona pellucida.
The BVD virus-like
particle (arrow) is shown in association with the inner cell mass
(ICM). The blastocelic cavity (Be) is indicated for orientation.
Uranyl acetate and lead citrate stain; 170,000 X.
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Figure 5. A transmission electron micrograph of a section
from a live embryo without a zona pellucida showing a virus-like
structure (arrow) that morphologically resembles the BVD virus.
This transmission electron micrograph was taken within the cyto
plasm of a trophoblast cell. Uranyl acetate and lead citrate stain;
192,000 X.
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Ultrastructural observations of each treatment group including
live embryos, with and without zona pellucida gave no indication of
cellular degeneration.

Abundant mitochrondria containing low electron-

dense matrices and stacked, laminar cristae were present in all sec
tions observed.

Identification of endoplasmic reticulum and large

nucleus with prominent nucleolus and distinct nuclear membranes sug
gested that cellular mechanisms were probably not affected adversely
by the presence of the BVD virus.

Virus-like particles have been

observed in mouse embryos without any evidence of cellular degenera
tion of the associated organelles (Van Blerkom and Motta, 1979).
Observations of dead embryos with and without zona pellucida
by TEM (figures 6 and 7) revealed cytoplasmic degeneration and abun
dance of granular and myelinated figures.

No virus-like particles

resembling the BVD virus were observed in any of the dead embryoswith or without the zona pellucida.

102

Figure 6. A transmission electron micrograph of a section
from a dead embryo with an intact zona pellucida.
The electron
dense zona pellucida (ZP) surrounds the granulated cytoplasm.
Uranyl acetate and lead citrate stain; 49,500 X.
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Figure 7. A transmission electron micrograph of a section
from a dead embryo without a zona pellucida coarse granulation and
vesiculation of the cytoplasm; (*) indicates the absence of the
zona pellucida.
Uranyl acetate and lead citrate stain; 65,000 X.

105

CHAPTER III

DEVELOPMENT OF THE BOVINE BLASTOCYST FOLLOWING
MICRO-INJECTION WITH BOVINE VIRAL DIARRHEA

Introduction
Interest in the effect of viruses on mammalian development has
largely focused on teratology, with experimental studies primarily
devoted to the fetus after implantation.

This area of concern was

most intensively researched because the mammalian embryo prior to
the implantation stage is thought to be almost impervious to tertatogenic agents (Wilson, 1965).
Inconsistent reports have suggested that some virus particles
can penetrate the zona pellucida and arrest development of mouse
embryos.

Research with other viruses has indicated that the zona

pellucida was impervious,

and this has led to the accepted method

of studying viruses associated with embryos following removal of the
zona pellucida.
BVD virus has been reported to be unable to penetrate the
zona pellucida of bovine embryos (Singh et al., 1982a).

This

finding was not obtained from electron microscopic evaluations
but from viral assays.

Substantial amounts of viral particles must

be present for the viral assay system to be positive.

This high

level of assay sensitivity may not account for a small amount of
viral particles that may be able to penetrate the zona pellucida.
106
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In order to infect intact preimplantation embryos with a
virus, techniques of micro-injection were incorporated in this
experiment.

Linn (1966) developed a method of injecting fertilized

one-cell mouse ova, by the use of a Leitz micromanipulator "eggholder" pipette and a small injection pipette.

The small diameter

of the injection pipette (1 ym) was used to pierce the elastic zona
pellucida and vitelline membrane of mammalian embryos.

Lin and

Monie (1973) reported no reduction in survival of micro-injected
mouse blastocysts when compared with non-injected control blasto
cysts.

Glass et al.

(1974) used the technique developed by Linn

(1966) to study the effect of Newcastle disease virus using mouse
embryos.

Injection of the virus directly into the blastocoele

resulted in 71 percent degeneration of the blastocysts while 93
percent of the injected controls (without virus) developed in vitro
and appeared normal.
The objectives of this experiment were:
1.

To evaluate survivability of bovine blastocysts in an
in vitro culture system after penetration of the zona
pellucida, vitelline membrane and trophoblast membrane
using micro-injection techniques.

2.

To inject BVD virus directly into the blastocelic cavity
of bovine blastocysts using micro-injection techniques
with subsequent culture as an indication of embryo
viability.
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Materials and Methods
Experimental Embryos.

A total of sixty bovine blastocysts

were collected from crossbred Angus, Hereford and Brahman donor
cattle superovulated with 40-45 mg of follicle-stimulating hormone

22

(FSH) administered intramuscularly (IM) in 5 mg injections twice
daily for four days.

Superovulatory treatment began on days 8-12

of the estrous cycle (estrus = day 0).
analogue of prostaglandin F^^

24

Prostaglandin F 2 a

23

> or an

, was administered IM 48 hours after

the initial FSH injection and estrus was expected within two days
of the administration of the luteolytic agent.

Donors were insemi

nated with forzen-thawed semen from bulls that had been tested and
found seronegative for BVD virus.

Non-surgical embryo recovery was

employed 7.5 days after the first insemination of the donor.
Embryos were flushed from the donor's uterus with Dulbecco's
PBS with 2 percent FCS containing antibotics and an antimycotic
(appendix table 2).

Blastocysts and expanded blastocysts were

morphologically classified and assessed morphological grading scores
using phase-contrast optics (100 X).
assessed as described in Chapter I.

Fluorescence scores were
Only blastocysts of morpho

logical grades less than or equal to 2, with fluorescence scores
of 3 or greater were utilized in this experiment.
22

R
FSH-P , Burns-Biotec, Omaha, Nebraska.
Lutalyse

(dinoprost tromethamine), Upjohn Co., Kalamazoo,

Michigan.
n /

Estrumate
(cloprostenol sodium), Haver-Lockhart, Bayvet
Division, Culter Laboratories, Inc., Shawnee, Kansas.
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Measurements were made of the diameter of each blastocyst's cellular
mass, excluding the zona pellucida, by the use of a calibrated ocular
micrometer.

25

Measurements were converted to microns by determining

that an ocular micrometer reading of 129 equaled a distance of 100
microns.

Blastocysts were randomly assigned across donors to three

treatment groups (20 blastocysts per treatment).
groups were as follows:

The treatment

(A) control blastocysts, no injection;

(B) control blastocysts injected with medium without BVD virus and
(C) blastocysts injected with medium containing BVD virus.
Micro-injection of Blastocysts.

Prior to micro-injection

procedure, embryos were held individually in 35 x 10 mm petri-dishes
filled with Dulbecco's PBS with 10 percent fetal-calf serum (FCS),
and antibiotics and an antimycotic (appendix table 9) at 22 to 24 C.
For micro-injection manipulation blastocysts were transferred to
a 2 ml drop of control medium (Treatment B) consisting of Dulbecco's
PBS + 10 percent Goat Serum (GS) (appendix table 4) or a 2 ml drop
3.5
of Dulbecco's PBS + 10 percent GS medium containing 10 ' T C I D ^
per .025 ml of BVD virus (Treatment C).

Each blastocyst was

securely immobilized by a smooth suction pipette held by the
left-hand Leitz micro-manipulator arm,
silastic tubing to a screw-syringe.

26

which was connected by

The micro-injection pipette

was held in place by the right-hand Leitz micro-manipulator arm.
O C

Ocular Micrometer, Baush and Lomb, Rochester, New York.
26

Leitz Micromanipulator, E. Leitz, Wetzler, Germany.
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The micro-injection pipette was connected by non-expandable polyethylene tubing to a 1 ml Hamilton glass syringe
placed by a sensitive micrometer.

27

that was dis

Low viscosity paraffin oil was

filled throughout the Hamilton syringe, polyethylene tubing and
throughout the injection pipette.

Injection medium was aspirated

into the injection pipette by negative pressure in the calibrated
syringe and displaced by turning the micrometer at consistent
volumes.

Using the micro-injection pipette which was tapered over

a length of approximately 1.5 cm to a diameter of 3 ym at the tip
approximately .0022 yl of medium (either control or BVD virus
suspension) was injected directly into the blastocoele by piercing
the highly elastic zona pellucida, vitelline and trophoblastic
membranes.
blastocysts.

Care was taken to avoid the inner cell mass of the
Treatment A blastocysts remained in individual

dishes in Dulbecco's PBS with 10 percent FCS until all other
treatment embryos were processed.

Blastocysts in Treatment B were

treated before those in Treatment C to prevent contamination by the
experimental use of BVD virus since the same injection pipette
was utilized for each series.

Treatment C blastocysts were washed

three successive times in medium of PBS with 10 percent FCS after
injection with BVD virus.
In Vitro Culture Procedures.

Evaluation of survival of

all blastocysts were assessed by in vitro culture for 48 hours.
27

Hamilton Glass Syringe, Hamilton Co., Whittier, California.

Ill

Blastocysts were individually cultured in Ham's F-10 medium supple
mented with 10 percent FCS (appendix table
atmosphere of 5 percent CO 2

9 ) at 37°C in a humidified

in air (Wright et al., 1976a,b).

Develop

ment of blastocysts in culture was evaluated at 24 h intervals at
100 X using phase-contrast and fluorescent microscopy.

Blastocysts

were initially transfered to individual petri-dishes (35 x 10 mm)
with Dulbecco's PBS with 10 percent FCS and morphological classi
fication, morphological grade, fluorescence and size of the cellular
mass were assessed.

Resulting positive or negative morphological

development was also determined by evaluating progression in embryo
stage from previous evaluations.

Blastocysts were returned to fresh

Ham's F-10 medium and replaced in a 37°C humidified atmosphere
of 5 percent CO 2

in air for an additional 24 h of culture.

Eval

uation was repeated at the end of the 48 h culture period and
blastocysts were fixed for transmission electron microscopic eval
uation as described in Chapter II.
Statistical Procedures.

The analysis of variance proce

dures of SAS 79 was used for the analysis of the data and Duncan's
Multiple Range Test was used to test differences among means.
Resulting development in culture, morphological grade, fluorescence
and size of blastocysts were analyzed using a split plot design with
treatments (A, B and C) as the main effect and time in culture (0,
24 and 48 h) as the sub-unit.
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Results and Discussion
Analysis of variance (table 20) indicated that treatment
was not a source of significant variation for development, grade,
fluorescence or diameter of cell mass parameters of experimental
blastocysts.

Significant variation was indicated in the time in

culture for all parameters of experimental blastocysts for develop
ment, grade, fluorescence and diameter of cell mass.

The time by

treatment interaction was not a significant source of variation
indicating that the responses due to treatment did not change over
time of the culture period.
Means for percent development in culture, assessments for
grade and fluorescence and diameters of cell mass of treated
embryos are shown in table 21.

Developmental rates of blastocysts

were similar for all treatments, although blastocysts which were
micro-injected with BVD virus (Treatment C) tended to develop at
the highest rate.

Similar results were also found between the three

treatments for grade assessments, although Treatment C blastocysts
had the lowest grade assessments indicating higher quality.

Fluo

rescence scores of Treatment C blastocysts were also higher than
both Treatment A and B blastocyst but means were similar.

Diameter

of cell mass of microinjected control blastocysts were larger than
either non-injected control blastocysts (Treatment A) or BVD virus
injected blastocysts (Treatment C ) .

Non-injected control blasto

cysts (Treatment A) had the smallest diameter of cell mass.

Micro

injected blastocysts of both Treatments B and C tended to hatch
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TABLE 20.

ANALYSIS OF VARIANCE FOR PERCENT DEVELOPMENT,
GRADE, FLUORESCENCE AND DIAMETER OF CELL MASS
OF MICRO-INJECTED AND CONTROL EMBRYOS

Mean squares
Source
Treatment
^
Embryo (Treatment)
Time
Time x Treatment
Error b
1
error a.
**P < .01.

df
2
57
2
4
114

Development
.067
.101
1.550**
.067
.082

Grade
.235
.744
5 .705*
.288
.566

Fluorescence

Diameter

.422
.181
220.176**
.168
.213

10587.308
4511.425
106866.320**
1878.371
1780.762
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TABLE 21.

Treatment

MEAN PERCENT DEVELOPMENT, GRADE, FLUORESCENCE,
AND DIAMETER OF CELL MASS OF TREATMENT
EMBRYOS AVERAGED OVER TIME

(n)

Development

Grade

Fluorescence

Diameter3

A2

60

88.335
+1.30

1.43
+ .30

1.32
+.02

170.69
+229.89

B3

60

85.00
+1.30

1.49
+ .30

1.38
+.02

197.11
+229.89

C4

60

91.67
+1.30

1.36
+.30

1.48
+.02

181.49
+229.89

^"Diameter of cell mass measured in micrometers (ym) .
2

A = control blastocysts, no injection.

3
B = control blastocysts injected with medium without BVD virus.
4C = blastocysts injected with medium containing BVD virus.
3Mean plus or minus standard error.
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through the point of puncture of the zona pellucida than non-injected
blastocysts during the 48 hour culture period, which probably account
for the larger diameter of the cell mass when evaluated.

Negative

effects were not observed in blastocysts injected with .0022 pi of
3.5
BVD virus (10 * TCID^ q /.025 ml) for development in culture, grading
or fluorescence assessments and diameter of cell mass as compared to
blastocysts injected with control medium or non-injected control
blastocysts during the 48 hour culture period.

Transmission elec

tron microscopic evaluation of BVD virus injected blastocysts
revealed virus-like particles which morphologically resembled the
BVD virus in close association with the trophoblastic membranes
(figure 8).
Means for percent development, grade, fluorescence and
diameters of cellular mass of blastocysts at 0, 24 and 48 hours of
in vitro culture as shown in table 22.
cyst development decreased.

As time increased blasto

Blastocyst development was significantly

reduced at the 48-h evaluation as compared with the 24- and 0-h
evaluation, which were not significantly different.

Grade assess

ments were significantly increased, indicating reduce blastocyst
viability at the 48 h evaluation, although grade assessments were
not different at the 24 h and 0 h assessment.

Mean fluorescence

scores also decreased significantly as time increased.

Fluores

cence scores of blastocysts were higher upon initial evaluation (Oh)
and were significantly reduced at each 24 h increments of evaluation.
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Figure 8. A transmission electron micrograph of a section
from a hatched blastocyst 48 hours after micro-injection with BVD
virus.
A BVD virus-like structure is shown within the cytoplasm
of a trophoblast cell. Uranyl acetate and lead citrate stain;
204,800 X.
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TABLE 22.

Time

n

0 h

60

24 h

48 h

M E M PERCENT DEVELOPMENT, GRADE, FLUORESCENCE
M D DIAMETER OF CELL MASS OF MICRO-INJECTED
M D CONTROL EMBRYOS AFTER CULTURE FOR
48 HOURS AT 37 C1

Development

Grade

Fluorescence

Diameter

0 0 .ooa3
+1.05

1.23a
+ .07

3.59a
+ .02

137.00a
+229.8

60

95.00a
+1.05

1.26a
+ .07

.51b
+ .02

192.48b
+229.8

60

70.00b
+1.05

1.78b
+.07

.07°
+ .02

219.83C
+229.8

1

^Means combined over treatments.
2
Diameter of cell mass measured in micrometers (ym).
O

Mean plus or minus standard error.
a,b,cValues in the same column with different superscripts
differ (P < .05).

2
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At the 48 h evaluation, less than 15 percent of the cultured blasto
cysts showed fluorescence.

Mohr and Trounson (1980) have shown

that 50 percent of the initial intracellular fluorescein was lost
in 30 minutes at 37 C and less than 5 percent remained after 2 hours.
Loss of fluorescence was not considered as an indication of decrea
sing blastocyst viability since long incubation times were employed
in the present experiment.

Blastocyst diameter of cell mass were

significantly higher at each 24 h evaluation, indicating blastocyst
growth throughout the 48 h culture period.

The increased diameter

of cellular mass also indicated optimum culture techniques were
employed along with the fact that 73 percent of all blastocysts
began or completed hatching from the zona pellucida.
et al.

Wright

(1976a,b) have shown that in vitro cellular growth and

hatching were associated with optimum culture techniques.

Diameter

measurements of experimental blastocyst in this study were similar
to previously reported values of 7.5 day old bovine blastocysts
(Hamilton and Laing, 1946; Chang, 1952; Olds et al., 1968).

Further

more, no reduction in development was indicated by micro-injection
and culture techniques developed in this experiment.

In this study,

viability indicators were utilized during a 48 hour culture period,
whereas a longer culture time may have revealed different results.

CHAPTER IV

EFFECT OF TRANSFERRING BOVINE VIRAL DIARRHEA
(BVD) VIRUS-EXPOSED BOVINE EMBRYOS INTO RECIPIENTS

Introduction

To provide conclusive evidence that embryo transfer can
be used in a disease prevention manner, similar to those techniques
used routinely by artificial insemination, well designed, controlled
experimentation must be provided.
BVD virus has been incriminated in abortion, fetal wastage
and congenital malformation and infertility (Archbald, 1979).
utero

In

inoculation of superovulated donor cows resulted in the

presence of BVD virus-like particles within embryos collected
three days following infection (Archbald, 1979).

Therefore, it

is theoretically possible to transmit the disease via embryo
transfer.
Experimentation utilizing embryo transfer into recipients
as a means for assessing the exposure of an embryo to virus has been
utilized in mice by Chapman et al.

(1974).

The resulting fetuses

were found to contain virus at a high incidence.

Wrathall (1979)

demonstrated that porcine embryos infected in vitro with porcine
parvovirus (PRV) could transmit the disease to recipient gilts, whose
serological status was converted and PRV virus was detected in the
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uterine lymph nodes.

Also observed in the recipient gilts were

distinct histopathological changes in the uterine epithelium and
ovaries, but PRV virus was not isolated from these tissues.
et al.

Bolin

(1982) found similar results in embryo transfer studies with

pseudorabies virus in swine.

These researchers infected potential

embryo donors immediately after mating with intranasal suspensions
of pseudorabies virus along with a group of non-infected donors
whose embryos were infected in vitro and transferred.

All recip-

g

ients of in vitro infected embryos (10

CCID of pseudorabies virus)

seroconverted and two of five recipients into which intranasal
infected donor embryos were transferred also seroconverted.

One

of seven positive recipients farrowed and the piglets, which were
tested prior to receiving colostrum, showed no evidence of pseu
dorabies virus infection.
No literature is available that utilizes bovine embryo
transfer as a means of assessing virus interaction with the embryo.
The outcome of transferring virus-exposed embryos into clean recip
ients is the ultimate test in the evaluation of embryo transfer as
a tool in disease prevention (Eaglesome, 1980).
The objectives of this experiment were:
1.

To evaluate the pregnancy rate of subsequently trans
ferred BVD virus-exposed embryos into "clean" recipients.

2.

To monitor the serological profiles of each recipient
after transfer of BVD virus-exposed embryos.
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Materials and Methods
Experimental Embryos.
collected from crossbred

A total of 100 bovine embryos were

Angus, Hereford and Brahman donor cows

superovulated with 40 to 45 mg of follicle-stimulating hormone

9Q

(FSH)

administered intramuscularly (IM) in 5 mg injections twice daily for
4 days.

FSH treatment began between days 8 and 12 of the estrous

cycle (estrus = 0).

Prostaglandin F„
2a

29

(35 mg) was administered

at 48 hours after the initial FSH injection and estrus was expected
within 2 days of the injection of the luteolytic agent.

Donors were

inseminated with frozen-thawed semen from bulls that were seronega
tive for BVD.

Embryos were non-surgically collected on day 7.0

following the induced estrus.

The flushing medium was Dulbecco's

PBS supplemented with 2 percent FCS with standard concentrations
of antibiotics and an antimycotic (appendix table 2).

Embryos were

morphologically classified using phase-contrast optics (100 X) and
morphological grading scores assessed.

The FDA viability test was

utilized to assess fluorescence scores as shown in Chapter I.

Only

morula, advanced morula and early blastocysts of morphological grades
of 1 and 2 with fluorescence scores of 2 or greater were utilized
in this experiment.

Embryos were randomly assigned to two culture

systems containing 50 embryos each.

The culture systems were:

Control medium consisting of 1:1 combination of Dulbecco's PBS and
28
29

R
FSH-P , Burns-Biotec, Omaha, Nebraska.

R
Lutalyse
(dinoprost tromethamine), Upjohn, Co.,
Kalamazoo, Michigan.
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Minimum Essential Medium (MEM) as previously described in appendix
table 4, and the BVD virus-infected medium, which contained the
same constituents as the control medium but included the BVD virus.
Both control and BVD virus-exposed embryos remained in a humidified

air atmosphere at 37 C for 24 hours.

The BVD virus used in this

experiment was from the same lot as that described in Chapter II.
The titer of the stock virus used in this culture experiment was
also 10

4

and 10

5

TCID^ q /,025 ml.

Immediately after the 24-h culture

period the embryos of each culture system were washed by transferring
them through three 2 ml volumes of Dulbecco's PBS with 10 percent GS
(1:400 dilution).

A fresh handling pipette was used to transfer the

embryos to each successive wash.

After washing, the embryos were

assessed for their morphological classification, morphological grade
and fluorescence score.

Morphological development was also deter

mined by evaluating progression in embryo morphological classification
from pre-culture evaluations.
Non-surgical Embryo Transfer Procedures.

Immediately

following the post-culture evaluation 60 highest quality embryos
(30) embryos from each culture system) were selected for transfer
by non-surgical techniques into suitable recipients.

Embryos were

individually aspirated into .25 ml French semen straws.

30

The

straws were heat-sealed and placed horizontally in a test tube

30

.25 ml French Straws, M. Cassou, L'Aigle, France.
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surrounded by a 500 ml water jacket for transport to the transfer
location.

Cross-bred beef recipient females were selected from the

St. Gabriel Experiment Station Physiology Herd, which had not been
BVD vaccinated.

The recipients were naturally exposed to BVD virus,

and approximately 50 percent were known to have positive antibody
titers for BVD prior to the beginning of the experiment.
were observed twice daily for estrus activity.

Recipients

Appropriate recipients

had at least two previous estrous cycles of 18 to 24 days.

Recipients

were considered in synchrony when estrus, either natural or synchro
nized, was within a range of 4 days of the donor's estrus being
the mean of the 4 day period.

Non-surgical transfers were made

during the months of May through August, 1982.

Recipients were pre

pared for non-surgical transfer initially by rectal examination of
each ovary in order to characterize ovary size, folliclar develop
ment and consistency and location of the corpus luteum which
corresponded to the particular day of estrous.
of 3 to 5 ml of Carbocaine

31

Epidural injection

between the last sacral and first

coccygeal vertebrae caused relaxation of rectal contractions which
aided in palpation of the reproductive tract.
Straws containing the control and BVD virus-exposed embryos
were placed into a Cassou inseminating gun,

32

the heat-sealed end

cut and a 46 cm outer sheath slipped over the end of the straw-gun.
31
32

Carbocaine, Winthrop Laboratories, New York, New York.
Cassou Inseminating Gun, M. Cassou, L'Aigle, France.
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A 23 cm plastic drinking straw with one end covered by plastic coated
paper was then slipped over the end of the straw gun and a 12 cm
hemostat was attached to the open end of the drinking straw for a
handle.

The entire apparatus was inserted into the vagina of the

recipient female and manipulated into the external £s of the cervix
where the Cassou apparatus was forced through the plastic, coated
paper barrier on the end of the drinking straw.

The Cassou appa

ratus was then passed through the cervix and up into the uterine
horn ipsilateral to the ovary with the functional corpus luteum.
Recipients that have received BVD virus-exposed embryos were iso
lated for the entire length of the project.
Virus Isolation and Serologic Testing.

In order to verify

that active virus was present during the culture period, both the
control and BVD virus-infected culture medium were assayed for
cytopathic effects (CPE) following growth on bovine turbinate (BT)
monolayers (appendix table 6).

The initial washing medium was also

assayed for active virus and subsequent washes were assayed only if
the initial wash proved to be positive.

Serum samples from each

recipient were collected via jugular vein puncture at time of
transfer and for 2 week intervals for 6 weeks.

Sera were subjected

to a microtitration virus-neutralization test (VNT) in order to
quantitate BVD virus-neutralizing antibodies (Fulton et al., 1982;
appendix table 10).
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Plasma Samples and Progesterone Assay.
obtained via jugular venipuncture

Plasma samples were

of all recipients on the day of

transfer, three and fourteen days post-transfer for subsequent
progesterone analysis to verify luteal function.
in 15 ml heparinized vaccum tubes
following collection.

32

Blood was collected

and chilled to 4 C immediately

Samples were then centrifuged at 3000 rpm for

ten minutes and the plasma pipetted into 7 ml plastic screw top vials
for storage (-20 C) until analysis.

The day 14 post-transfer

sample corresponded to the approximate time of expected estrus, if
pregnancy was not maintained, and was used to indicate pregnancy
status early in gestation.

Twice daily estrus detection was also

utilized in order to obtain non-return rates.
Plasma progesterone levels were determined by a liquidphase radioimmunoassay (Abraham et al., 1971).

Progesterone was

extracted from plasma with reagent grade petroleum ether and recon
stituted in phosphate buffered saline (PBS-G).

Aliquots of the

reconstituted extracts were assayed with values corrected for percent
recovery.

Mean recovery of labelled progesterone from the plasma

was 92.3 percent.
The highly specific progesterone anti-serum, kindly supplied
by Dr. T. M. Nett of Colorado State University was diluted (1:2000)
in .1 percent gelatin buffer prior to use.

This same diluent was

■^Vacutainer (143 USP Units Sodium Heparin per 10 ml tube),
Becton-Dickinson and Co., Rutherford, New Jersey.

127

utilized in the preparation of the labelled progesterone (10,000 cpm/
200 yl) to formulate the standard curves.
Pregnancy Determination.

Rectal aplpation of the uterus

at 42 and 65 days post-transfer was utilized to determine pregnancy
in experimental recipients.

Recipients which had high progesterone

levels at 14 days post-transfer (> 2 ng/ml) and extended estrous
cycles after transfer of 5 days or greater than the mean of two
previous estrous cycles prior to transfer were considered as having
embryonic mortality.
Statistical Analysis.

The pre- and post-culture morphological

grade and fluorescence scores were determined at the onset and after
24 hours of in vitro culture.

Differences in these parameters between

control and BVD virus-exposed embryos were analyzed by Student's
t-test procedure (Steel and Torie, 1981).

Chi-square analysis was

utilized to test differences between control and BVD virus-exposed
embryos during the culture period for result in development.

Chi-

square analysis was also used to test differences in 42 day and 65
day pregnancy determination of control and BVD virus-exposed embryos.
Plasma progesterone levels of the recipients on the day of transfer,
3 and 14 days post-transfer were compared by the general linear model
procedure using a split-plot design with treatment as the main effect
and interval (day of sampling) as the sub-unit (Goodnight, 1979).
Duncan's Multiple Range Test was performed to determine differences
due to treatment and interval means, while the least square means
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were utilized for comparison of treatment means within an interval
for progesterone levels.
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Results and Discussion
Mean values for pre-culture and post-culture viability
indicators and percent development are shown in table 23.

Mean

pre-culture grades for control and BVD virus-exposed embryos were
similar and were not significantly different.

In addition fluo

rescence scores of embryos from each culture system were also similar.
After culture for 24 h, control and BVD virus-exposed embryos were
transferred through wash dilutions and reevaluated for grade and
fluorescence.

Post-culture grade assessment scores increased when

compared to pre-culture scores indicating lowered viability, while
post-culture fluorescence scores decreased verifying the indicated
lowered viability obtained in the grade assessments.

Post-culture

evaluations for control and BVD virus-exposed embryos were not
significantly different as to grade or fluorescence scores.
A total of 38 of 50 (76%) control medium-cultured embryos
developed iri vitro while 36 of 50 (72%) of the BVD virus-exposed
embryos showed positive in vitro development.

Although more con

trol embryos developed while in culture than BVD virus-exposed
embryos, no significant difference was found for development between
the two culture systems.

Singh et al.

(1982a) found similar results

for in vitro embryonic development of embryos exposed to BVD virus.
Virus isolation assays confirmed active BVD virus in
100 percent of BVD virus culture medium samples.

The control cul

ture medium and initial wash samples of each culture system were
negative for BVD virus.

TABLE 23.

Culture system

(n)

Control medium

50

Control medium
+ BVD virus

50

MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS
AND PERCENT DEVELOPMENT OF CONTROL AND BVD VIRUS-EXPOSED EMBRYOS1

Pre-culture
Grade Fluorescence

Post-culture
Grade
Fluorescence

1.61

% Developing

2.75
±.i4

1.66
+.15

1.16
+.16

38

76

±.n
1.46
+ .11

3.00
+. 13

1.86
+.16

1.12
+ .16

36

72

•^Student's t-test used to test differences among means.
2

N o . of embryos
developing in vitro

Mean plus or minus standard error.
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Serum samples from recipients transferred with control and
BVD virus-exposed embryos were assayed for BVD antibody titers by
serum neutralization techniques.

In order to assess if seroconver

sion occurred in recipients after transfer, samples were analyzed at
transfer and for 2-week intervals for 6 weeks.

Representative values

of BVD serum antibodies for twenty recipients receiving control and
BVD virus-exposed embryos are shown in table 24.

No seroconversion

was detected during the six week period following transfer in any
recipient receiving either a control or BVD virus-exposed embryo.
From a total of 60 recipients, 28 females (46.6%) had positive serum
antibody titers for BVD at the time of transfer.

This percentage was

lower than that previously reported for Louisiana cattle (Seger, 1968).
Plasma samples from all recipients were assayed for proges
terone at three intervals to verify luteal function and to enable early
pregnancy determination.

Analysis of variance of plasma progesterone

concentrations indicated significant variation due to interval, but
treatment was not a source of significant variation.

Figure 9 shows

plasma progesterone concentrations of recipients transferred with
control and BVD virus-exposed embryos at three intervals.

Proges

terone concentrations of recipients receiving control and BVD virusexposed embryos on the day of transfer were not significantly dif
ferent (5.81 vs 5.88 ng/ml) along with the mean day 3 post-transfer
sample (8.26 vs 7.86 ng/ml).

Mean progesterone concentrations of

recipients of control embryos at 14 days post-transfer were higher than

TABLE 24.

REPRESENTATIVE VALUES OF BVD SERUM ANTIBODIES OF RECIPIENTS
NON-SURGICALLY TRANSFERRED WITH CONTROL OR BVD
VIRUS-EXPOSED EMBRYOS

BVD serum neutralization titers'^"
Treatment
Control embryos

BVD virus-exposed
embryos

Animal No.

Initial

2

Second week

Fourth week

Sixth week

1
2
3
4
5
6
7
8
9
10

+;
+;
+;
-;
-;
+;
-;
-;
+;
-;

1:2
1:4
1:16
1:4
1:2
1:8
1:4
1:4
1:2
1:4

+;
+;
-;
-S
+;
-;
-;
+;
-;

1:2
1:2
1:8
1:4
1:2
1:4
1:4
1:4
1:2
1:4

+;
+;
+;
-;
-;
+;
-;
-;
+;
-;

1:2
1:2
1:8
1:4
1:2
1:4
1:4
1:4
1:2
1:4

+;
+;
+;
-;
-;
+;
-;
-;
+;
-;

1:2
1:4
1:16
1:4
1:2
1:8
1:4
1:4
1:2
1:4

11
12
13
14
15
16
17
18
19
20

-;
-;
+;
+;
-;
+;
+;
-;
-;
-;

1:2
1:2
1:4
1:2
1:4
1:8
1:8
1:4
1:4
1:4

-;
-;
+;
+;
-;
+;
+;
-;
-;
-;

1:2
1:2
1:4
1:2
1:4
1:8
1:4
1:4
1:4
1:4

-;
-;
+;
-;
-;
+;
+;
-;
-;
-;

1:2
1:2
1:8
1:2
1:4
1:4
1:4
1:4
1:4
1:4

-;
-;
+;
+;
-;
+;
+;
-;
-;
-;

1:2
1:2
1:4
1:2
1:4
1:8
1:4
1; 4
1:4
1:4

■'‘Titer indicates highest dilution at which neutralization occurred or the lowest dilution tested
not exhibiting neutralization.
Serum sample taken at time of embryo transfer.

10.0r
Control

( n g /m l)

I

BVD Virus KSNS3

8.0

PROGESTERONE

t

6.0

2.0

Day of transfer

3 days
post-transfer

14 days
post-transfer

Figure 9. Progesterone levels of control and BVD virus embryo
transferred recipients at three intervals.
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mean progesterone concentration of recipients of BVD virus-exposed
embryos (4.31 vs 3.55 ng/ml), but the difference was not significant.
The higher progesterone concentrations although not different
(P > .05), gave an early indication that the control recipients could
be expected to have a higher pregnancy rate than the recipients
receiving BVD virus-exposed embryos.
Pregnancy was determined in experimental recipients at 42
and 65 days post-transfer by rectal palpation (table 25).

The number

of 42-day pregnancies for recipients in control embryos was higher
than that from recipients of BVD virus-exposed embryos, 8 of 30
(26.7%) and 5 of 30 (16.7%), respectively.

However, this difference

in pregnancy rate was not significantly different.

Determination of

pregnancy at 65 days revealed embryonic losses when compared to the
42-day pregnancy determination of the same recipients.

Embryonic

losses of recipients receiving control embryos (two pregnancies)
were higher than that of recipients transferred with BVD virus-exposed
embryos (one pregnancy).

Existing 65-day pregnancies and percent

pregnancy'rate for control embryos recipients were six and 20.0%,
while the number of pregnancies and percent pregnancy rate of recip
ients receiving BVD virus-exposed embryos was four (13.3%).

The

number of pregnancies for control and BVD virus cultured embryo
transferred recipients were not significantly different at the 65
day post-transfer pregnancy determination.
In order to explain the lower than normally expected preg
nancy rate for non-surgically transferred embryos,

attempts were made
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TABLE 25.

PREGNANCY RATES OF RECIPIENTS NON-SURGICALLY
TRANSFERRED WITH CONTROL AND BVD VIRUSEXPOSED EMBRYOS

n

No. 42-day
Pregnancies

% Pregnant

No. 65-day
Pregnancies

% Pregnant

Control
embryos

30

8

26.7

6

20.0

BVD infected
embryos

30

5

16.7

4

13.3

Treatment

Pregnancy determined by rectal palpation.
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to characterize high progesterone concentrations at the 14-day post
transfer sampling interval along with extended estrous cycles to
reveal losses due to embryonic mortality in both control and BVD
virus-exposed embryo transferred recipients.

Table 26 shows the

number of recipients transferred with embryos from each culture
system for high progesterone (> 2 ng/ml), extended estrous cycles
and embryonic mortality.

More recipients from the BVD virus-exposed

culture system had high progesterone concentrations at 14 days post
transfer and extended estrous cycles than control embryo transferred
recipients.

Embryonic mortality, defined as the combination of high

progesterone concentrations at 14 days post-transfer and estrous
cycles extended greater than 5 days than the mean previous pre-trans
fer estrous, was higher in BVD exposed embryo transferred recipients
(5 of 30; 16.7%) than in control embryo transferred recipients (3 of
30; 10%).
cant.

However, this difference was not statistically signifi

These embryonic losses may be accounted for by the high

environmental temperatures and humidity that recipients were sub
jected to during the process of the experiment.

Ulberg and Burfening

(1967) have supportive data showing that high air temperature caused
a reduced reproductive rate because of increased embryonic death
rate.

However, because of the small number of pregnancies obtained

in the present experiment, no conclusive statement can be made regar
ding the effect of the BVD virus on early embryonic mortality.
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TABLE 26.

PLASMA PROGESTERONE CONCENTRATIONS, EXTENDED ESTROUS CYCLES
AND EMBRYONIC MORTALITY OF RECIPIENTS TRANSFERRED
WITH CONTROL AND BVD-EXPOSED EMBRYOS

Control embry os
Variables

No. recipients

BVD-virus exposed embryos
%

No. recipients

%

1
High progesterone
Extended cycles

2

Embryonic mortality

3

14

46.7

16

53.3

5

16.7

6

20.0

3

10.0

5

16.7

Progesterone levels > 2 ng/ml plasma at 14 days post-transfer.
2

Estrous cycle extended greater than 5 days than previous pre
transfer estrous cycles.
3
Progesterone levels > 2 ng/ml at 14 days post-transfer and
extended estrous cycles post-transfer of 5 days or greater than
mean estrous cycles prior to transfer.

SUMMARY AND CONCLUSIONS

Data from a total of 402 bovine preimplantation embryos were
used to develop new techniques for estimating bovine embryo viability
and to investigate the effect of the virus of Bovine Viral Diarrhea
(BVD) on in vitro culture and subsequent embryo development.
A preliminary study (Chapter I) was conducted in order to
evaluate the use of fluorescein diacetate (FDA) to assess viability
of bovine embryos in vitro.

The evaluation of viability with FDA

was more sensitive than morphological grading assessments in its
ability to establish positive development in vitro of bovine embryos.
Although both viability indicators were highly correlated at both
pre-culture and post-culture evaluations, the more biologically
sensitive FDA test has the advantage of measuring both intercellular
enzyme activity and membrane integrity.

The FDA test was found to

be easily adapted to the general technique of embryo transfer and
was determined to be a useful aid in complementing morphological
grading techniques in accessing viability of bovine embryos iri vitro.
In Chapter II, live and dead embryos were exposed to BVD
virus in an in vitro culture system in an attempt to evaluate the
zona pellucida's ability to protect the developing embryo from BVD
virus particle penetration.

In vitro development was similar for

live embryos with and without the zona pellucida, indicating that
embryonic development was independent of the intact zona pellucida.

138

139

Viral isolation analysis of sonificated virus-exposed embryos proved
negative, along with attempts to quantitate the uptake of virus.
Due to some inefficiencies involved with conventional viral assays
and the small size of bovine embryos, further analysis was employed
utilizing transmission electron microscopy (TEM).

TEM revealed struc

tures in both live embryos with and without a zona pellucida, which
morphologically resembled the BVD virus.

The presence of these

"virus-like" particles indicated that the BVD virus can penetrate
the intact zona pellucida.

TEM evaluation of dead embryos both with

and without a zona pellucida showed vast cytoplasmic degeneration
and no "virus-like" particles that resembled BVD was observed.
Micro-injection of BVD virus, via micromanipulation (Chapter
III), directly into the blastocoelic cavity by piercing the zona
pellucida, vitelline and trophoblastic membranes of bovine blasto
cysts had no detrimental effect on in vitro development.

Further

more, blastocysts injected with BVD virus developed at a rate of
91.67 percent, which was higher than injected and non-injected con
trol blastocysts.

These results support those of Chapter II, when

embryos were exposed to BVD and no subsequent lowered development
was observed.

Previous research has indicated that the BVD virus

could inhibit mitosis of several mammalian cell types both iri vitro
and jin v i v o , although development of BVD-exposed embryos was not
effected.

The possibility that the virus was rendered non-infective

upon interaction with the embryos, or that early bovine embryos may
not be susceptible to BVD virus jin vitro cannot be distinguished in
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this study.

Although somatic cells are permissive for BVD virus, the

possibility for non-permissiveness of embryos to infection has been
reported.
In an attempt to utilize embryo transfer as a means of
studying viral infection and to provide evidence that embryo trans
fer can be used in a disease prevention manner, experimentation in
Chapter IV was developed.

One hundred bovine embryos cultured in

a control medium without BVD virus and a virus-infected medium
were evaluated initially for in vitro development and subsequently
non-surgically transferred to suitable recipients.

Control embryos

developed at a higher, but non-significant rate, than BVD virusexposed embryos.

Also, pregnancy rates were higher for control

embryos than for BVD virus-exposed embryos.
ferences were not statistically significant.

However these dif
Serological status

of recipients receiving control and BVD virus-exposed embryos did
not change over a six week post-transfer period, indicating either
that the BVD virus was not transmitted by the exposed embryos or
-medium, or that if virus was transmitted by the transfer technique
the level was below the immunological threshold of the recipients.
The fact that pregnancies were established from embryos exposed to
BVD virus suggests that embryo transfer may be useful in controlling
the disease in infected or seropositive donor cattle.

However, to

ultimately answer this question the pregnancy rate following transfer
of embryos micro-injected with BVD virus to Seronegative and Sero
positive recipients must be ascertained.
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APPENDIX TABLE 1.

EMBRYO MORPHOLOGICAL STAGES NORMALLY
FOUND ON SPECIFIC DAYS OF THE
ESTROUS CYCLE 3

Morphological Description

-cell
-cell
4-cell
8 -cell
16-cell
Morula
Tight Morula
Early Blastocyst
Blastocyst
Expanded Blastocyst
Hatching Blastocyst
1

2

aSeidel et al. (1980)

Days after estrus normally found

123455770

1

3
3
5
5
6

7
8

9

8 - 1 0

9-11
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APPENDIX TABLE 2.

Component
CaCl 2

gms / 1
0 . 1 0

KCL
MgS0 4 -7H20

0 . 2 0
0 . 1 0

NaCl
kh 2 po 4
NaH 2 P 0 4 -H 2

COMPONENTS OF DULBECCO'S PBS MEDIUM
FOR NON-SURGICAL BOVINE EMBRYO
COLLECTION PROCEDURE

8 . 0 0
0 . 2 0

0

Special Components
Fetal Calf Seruml
Penicillin
Streptomycin
Fungizone

2.16

m l / 1 0 0 ml
100 IU/ml
1 0 0
ug/ml
.25 ug/ml
2

Heat inactivated, virus screened and mycoplasma
tested.

APPENDIX TABLE 3.

Component
CaCl 2
KC1
MgS0 4 -7H20
NaCl
kh 2 po 4
NaH P0.-H„0
2
4 2
Special Components
Fetal Calf Serum^
Penicillin
Steptomycin
Fungizone

COMPONENTS OF DULBECCO'S PBS FOR
CULTURE MEDIUM USED IN FDA
VIABILITY TEST PROCEDURE*

gms /

1

0 . 1 0

0 . 2 0
0 . 1 0

8 . 0 0
0 . 2 0

2.16

m l / 1 0 0 ml
100 IU/100 ml
1 0 0
ug / 1 0 0 ml
.25 ug/100 ml

2 0

^Filtered through .22 pm millipore filter.

2

Heat inactivated, virus screened, mycoplasma
tested.

APPENDIX TABLE 4.

CONSTITUENTS OF COMPLETE MEDIUM FOR
CULTURE OF BOVINE EMBRYOS WITH BVD
VIRUS

Dulbecco's Phosphate Buffered Saline (PBS)
Component
CaCl 2

gms / 1
. 1 0

KC1
MgS0 4 -7H20

. 2 0
. 1 0

NaCl
kh 2 po 4

8 . 0 0
. 2 0

NaH 2 P 0 4 -H 2

0

2.16

Modified Minimum Essential Medium (MEM)
with Earle's Salts
Component
CaCl 2

mg/ 1

KC1
MgS0 4 (anhyd.)

400.00
97.67

NaCl
NaH 2 P0 4 -H20
D-Glucose
Phenol red
L-alanine
L-arginine-HCl
L-asparagine-H20
L-aspartic Acid
L-cystine-2 HC1
L-glutamic acid
L-glutamine
Glycine
L-histidine HC1-H20
L-isoleucine
L-leucine
L-lysine HC1
L-methionine
L-phenylalanine
L-proline
L-serine
L-threonine
L-tryptophane
L-tyrosine (disodium salt)

2 0 0 . 0 0

6800.00
140.00
1 0 0 0 . 0 0
1 0 . 0 0

8.90
126.00
15.00
13.30
31.29
14.70
292.00
7.50
42.00
52.00
52.00
72.50
15.00
32.00
11.50
10.50
48.00
1 0 . 0 0

52.10

APPENDIX TABLE 4. (Continuation)

MEM with Earle's Salts
Component
L-valine
D-Ca pantothenate
Choline chloride
Folic acid
i-inositol
Nicotinamide
Pyridoxal HC1
Riboflavin
Thiamine HC1

mg/i
46.00
1 . 0 0
1 . 0 0
1 . 0 0
2 . 0 0
1 . 0 0
1 . 0 0
. 1 0
1 . 0 0

LSU Virology Lab Modification of MEM:
.01N NaHC0 3

in 1 1

.01N NaOH
in 1 1
.025 M 4-(2-hydroxyethyl)-l-piperazin<
ethande sulphanic acid (HEPES)
(Preparatory Instructions)
Mixture of PBS and MEM 1:1
Addition of 10% heat inactivated goat serum (V/V)
Addition of 100 IU Pennicillin, 100 yg Streptomycin,
.25 yg Fungizone/ml
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APPENDIX TABLE 5.

LABORATORY PROCEDURES FOR TRANSMISSION
ELECTRON MICROSCOPY OF BOVINE EMBRYOS

Procedure

Description of procedure

1.

Pre-fixation

2.

Wash

3.

Post-fixation

4.

Wash

5.

Dehydration

Transfer embryos to 3% glutaraldhyde in .1M sodium phosphate
buffer (7.4 pH; 490 mOsm) for
1
hour.
Transfer embryos to three conse
cutive wash solutions of .1M
sodium phosphate buffer at 15
minute intervals.
Transfer embryos to 1% osmium
tetroxide in .1M sodium phosphate
buffer (7.4 pH) for 1 hour.
Transfer embryos to three conse
cutive wash solutions of .1M
sodium phosphate buffer at 15
minute intervals.
Transfer embryos to ethanol
concentrations in series of 60%,
70%, 80%, 90%, 90%, 100%, 100%,
100% for 15 minutes each.
Addition of approximately .5-lml
epon embedding plastic to 2-3ml
1 0 0 %
ethanol containing the
embryos.
Single embryos are transferred
to pure epon contained in 7ml
plastic weigh boats and held
at 50°C for 72 hours.
Embryos are sectioned with
Sorvall ultramicrotome equipped
with a diamond knife at a thick
ness of 1 0 0 X, and five to ten
sections transferred to 2 0 0
mesh grids.
Thin section were stained with
uranyl acetate and lead citrate
each for 1 0 - 2 0 minutes.
Grids were examined using a Zeiss10 TEM at various magnifications.

6

.

7.

8

.

9.

10.

Infiltration

Polymerization

Sectioning ,

Section staining

Grid Evaluation
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APPENDIX TABLE

Medium Used:

6

.

1.

2.
3.
4.

5.

.

Minimum Essential Medium (MEM) with 10% Goat
Serum (GS) with 200 IU Pennicillin, 200 yg
Streptomycin and .50 yg Fungizone/ml.

Tissue Culture System:

Procedure No.

LABORATORY PROCEDURE FOR VIRUS
ISOLATION IN MONOLAYER CELL
CULTURES 3

Bovine turbinate (BT) monolayers
in 24 well flat bottom sterile
tissue culture plates.
Description of procedure
Two wells per sample are seeded with
a constant suspension of BT cells.
Each of two wells received .5ml of
prepared sample.
Virus isolation plates incubated in a
humidified air atmosphere at 37C.
Each well will be read for cytopathic
effects (CPE) once daily through
inverted microscope with final
reading for CPE made seven days post
infection.
Uninfected control wells serve as a
cell control on each plate.

aFulton, R. W . , W. T. Springer, H. V. Hagstad, S. S. Nicholson,
N. J. Pearson, M. M. Downing and M. T. Potter, 1982.
IBR virus and
PI^ virus in nasal flora of dairy calves. Bovine Practioner 17:59.
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APPENDIX TABLE 7.

LABORATORY PROCEDURES FOR FLUORESCENT
ANTIBODY (FA) STAINING

Procedure

Description of procedure

1.

Conjugation of immunoglobulin

Immunoglobulin to BVD virus
is separated from serum and
concentrated and combined
chemically with a stable
fluorescent dye. The labeled
antibody is used to detect
the specific antigen (BVD
virus).

2.

Direct Method

Specific antibody with fluo
rescent dye obtained from
U.S.D.A. N.V.S.L., Ames,
Iowa, was allowed to react
with suspected viral con
taminated samples. A positive
reaction with antibody and
antigen (BVD virus) results
in a brillant glow when
observed under fluorescent
microscopy.
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APPENDIX TABLE

Definition:

8

.

LABORATORY PROCEDURES FOR
TITRATION OF VIRUS

A virus titration is a quantitative
determination of viral activity, i.e.,
the smallest amount of viral suspension
which can produce disease, lesions, or
some recognizable effect in the host.

Procedure

Description of procedure

1.

Preparation of serial dilutions

Ten fold dilutions of BVD
virus suspensions in MEM
over an indicator system
of Ovine Fetal Turbinate
(OFT) cells in 96 well
plates.

2.

Cell controls

Uninfected control wells
serve as a cell control
on each plate.

3.

Incubation

Plates are incubated in a
humidified air atmosphere at
37C.

4.

CPE observation

Each well of the titration
plate are observed each
day for seven days.

5.

Calculation of virus titers

Titers are expressed as the
reciprocal of the highest
dilution of the virus, which
are expressed as the 50%
tissue culture infective dose
(t c i d 5Q).

APPENDIX TABLE

9.

COMPONENTS OF HAM'S F-10 FOR
CULTURE MEDIUM USED IN MICRO
INJECTION PROCEDURE 1

Components
Inorganic salts
CaCl 2 -2H20

mg/1
44.1

CuS0 4 ’5H20

.0025

FeSO^•7H20

.834

KC1
KH 2 P0 4
MgS04*7H20
NaCl
NaHC0 3
NaHPO^•7H20
ZNSO 4 •7H20
Other Components
Glucose
Hypoxanthine
Lipoic acid
Phenol red
Sodium pyruvate
Thymidine
Amino acids
L-alanine
L-arginine HC1
L-asparagine H20
L-aspartic acid
L-cysteine
L-glutamic acid
L-glutamine
Glycine
L-histidine HC1-H20
L-isoleucine
L-leucine
L-lysine HC1
L-methionine
L-phenylalanine
L-proline
L-serine
L-threonine
L-tryptophan
L-tyrosine
L-valine

285.0
83.0
152.8
7400.0
1200.0
290.0
.0288
1100.0
4.0
.2
1.2
110.0
.7
9.0
211.0
15.01
13.0
25.0
14.7
146.0
7.51
23.0
2.6
13.0
29.0
4.48
5.0
11.5
10.5
3.57
.6
1.81
3.5

APPENDIX TABLE

Components
Vitamins
Biotin
D-Ca pantothenate
Choline chloride
Folic acid
i-inositol
Niacinamide
Pyridoxine HC1
Riboflavin
Thiamine HCl
Vitamin Bj^
Special Components
Fetal calf serum^
Penicillin
Streptomycin
Fungizone

9.

(Continuation)

mg/i
.024
.175
.698
1.320
.541
.615
.206
.376
1 . 0 0 0

1.360
1 0
m l / 1 0 0 ml
100 IU/ml
1 0 0
yg/ml
.25 yg/ml

"''Filtered through .22 ym millipore filter.
^Heat inactivated, virus screened, mycoplasma
tested.

169

APPENDIX TABLE 10.

Tissue culture system:
Beta Neutralization:

LABORATORY PROCEDURES FOR SEROLOGIC
TESTING FOR BVD VIRUS NEUTRALIZING
ANTIBODIES

Ovine fetal turbinate (OFT) monolayers
in 96-well microtitration plates
100 T C I D ^ of BVD Singer Strain was
incubated with two-fold serum dilutions.

Procedure No.

1.
2.
3.

Description of procedure
Serum was heat inactivated at 56 C for
30 seconds.
.25 ml MEM medium with antibotics was
added to each well.
Undiluted serum (.05 ml) was added to
the first well and serial 2 -fold dilution
were made with sterile microdiluting
loops (. 5 ml).
TCID^ q /,025 ml) was added to each serum
dilution.
Plates were agitated and incubated for
1
hour at room temperature.
Dispersed OFT cells (.05 ml) was added
to each well and incubated at 37 C for
7 days.
Virus neutralizing titers (VNT) were
expressed as the final dilution of
serum that completely inhibited viral
CPE in duplicate wells.
For each sera tested (four sera per
recipient), serum and virus controls
were included along with a cell control
well. Also included were proven posi
tive or negative sera.
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